Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# The Lieber Institute for Brain Development | Research & Discovery

Unraveling the biological mechanisms behind mental illness.

## Sitemaps

- [XML Sitemap](https://www.libd.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Divergent Transcription in the BDNF Locus: Two Novel Genes That May Rewrite Our Understanding of BDNF Regulation and Schizophrenia Risk](https://www.libd.org/divergent-transcription-in-the-bdnf-locus-two-novel-genes-that-may-rewrite-our-understanding-of-bdnf-regulation-and-schizophrenia-risk/) - Divergent Transcription in the BDNF Locus: Two Novel Genes That May Rewrite Our Understanding of BDNF Regulation and Schizophrenia Risk New findings from the Lieber Institute challenge long-held assumptions about the BDNF locus and introduce a compelling regulatory framework with direct psychiatric relevance For decades, the BDNF locus has been one of the most intensively
- [Your Brain Has Hidden "Volume Controls"](https://www.libd.org/your-brain-has-hidden-volume-controls/) - A groundbreaking discovery at the Lieber Institute reveals secret genetic regulators that may hold the key to understanding schizophrenia Think about the last time you learned something new, a name, a skill, a shortcut on your commute. Behind every one of those moments, a tiny protein in your brain called BDNF (Brain-Derived Neurotrophic Factor) was
- [How Coexpression Networks Reveal the Trans-Regulatory Architecture of Schizophrenia Risk](https://www.libd.org/schizophrenia-ecosystem/) - Beyond Cis-Regulation: How Coexpression Networks Reveal the Trans-Regulatory Architecture of Schizophrenia Risk The field of psychiatric genetics has reached an inflection point. While genome-wide association studies (GWAS) have identified hundreds of loci associated with schizophrenia, translating these statistical associations into mechanistic insights remains challenging. Most risk variants reside in non-coding regions, presumably affecting gene regulation,
- [ADARB1 Overexpression and Premature RNA Recoding](https://www.libd.org/adarb1-overexpression-and-premature-rna-recoding/) - ADARB1 Overexpression and Premature RNA Recoding: A New Post-Transcriptional Axis in Down Syndrome Neuropathology Fetal brain transcriptomics reveal dosage-sensitive RNA editing dysregulation that may fundamentally reshape our understanding of trisomy 21 Beyond Gene Dosage: The Timing Problem in Trisomy 21 We’ve long understood the genetic basis of Down syndrome—trisomy of chromosome 21 leading to approximately
- [A New Molecular Map of a Brain Region Central to Cognitive Control and Emotion](https://www.libd.org/a-new-molecular-map-of-a-brain-region-central-to-cognitive-control-and-emotion/) - Every day, our brains continuously integrate information about the world around us with our goals, emotions, and past experiences to guide our thoughts and actions. One region that plays a central role in this process is the dorsal anterior cingulate cortex (dACC), a small but highly interconnected area of the brain involved in cognitive control,
- [A Spatiomolecular Atlas of the Human Nucleus Accumbens (NAc)](https://www.libd.org/a-spatiomolecular-atlas-of-the-human-nucleus-accumbens-nac/) - The Lieber Institute's comprehensive integration of single cell and spatial transcriptomics redefines our understanding of NAc architecture, and opens new avenues for translational neuroscience The nucleus accumbens (NAc) has occupied a central position in reward neuroscience for decades. Its GABAergic medium spiny neurons (MSNs), dopaminergic inputs from the ventral tegmental area, and glutamatergic afferents from
- [Remembering Steve Lieber](https://www.libd.org/remembering-steve-lieber/) - REMEBERING STEVE LIEBER Today, we pause to honor and remember Steve Lieber, a visionary philanthropist, mentor, and cherished friend whose life profoundly shaped the landscape of mental health research. Steve’s dedication, intelligence, and generosity created ripples across the scientific community that will be felt for generations to come. Steve left us six years ago during
- [A New Path to Understanding Schizophrenia](https://www.libd.org/a-new-path-to-understanding-schizophrenia/) - Imagine trying to understand how a city works by only looking at individual buildings, while ignoring the roads, phone lines, and internet connections that link them together. That's essentially what scientists have been doing when studying the genetics of schizophrenia—until now. Researchers at the Lieber Institute for Brain Development have developed a revolutionary approach that
- [Scientists Just Mapped the Brain's Reward Center](https://www.libd.org/scientists-just-mapped-the-brains-reward-center/) - Scientists Just Created the First Detailed Map of a Key Reward Center in Your Brain, And It Could Change How We Treat Addiction and Mental Illness A landmark study from the Lieber Institute reveals hidden complexity in a brain region that controls craving, motivation, and joy Picture the last time you felt genuinely excited about
- [Board of Directors Emily Conley, Ph.D.](https://www.libd.org/board-of-directors-emily-conley-ph-d/) - Lieber Institute for Brain Development Welcomes Emily Conley, Ph.D. to Board of Directors Baltimore, MD (April 10, 2026) —The Lieber Institute for Brain Development is pleased to announce the appointment of Emily Conley, Ph.D. to its Board of Directors. Dr. Conley is a highly accomplished biotech executive and board leader with extensive experience building and
- [Scientists Discover Hidden "Editing Error" in Down Syndrome Brains](https://www.libd.org/scientists-discover-hidden-editing-error-in-down-syndrome-brains/) - A new study reveals that an extra chromosome triggers a cascade of genetic "typos" during early brain development—and understanding this process could open new doors for intervention Down syndrome affects approximately 1 in 700 babies born in the United States—about 6,000 babies each year. Worldwide, it’s estimated that over 6 million people have Down syndrome.
- [Lieber Researchers Create Brain-Sparing Benzodiazepine for Gut Pain](https://www.libd.org/lieber-researchers-create-brain-sparing-benzodiazepine-for-gut-pain/) - Lieber Institute Researchers Develop a New Kind of Benzodiazepine Candidate Designed to Quiet Gut Pain - Without Entering the Brain Baltimore, MD (Jan 06, 2026) — For millions of people living with irritable bowel syndrome (IBS), functional dyspepsia, and related visceral pain syndromes, chronic abdominal pain isn’t just uncomfortable, it can be relentless, unpredictable, and
- [Keri Martinowich, Ph.D., Chief Scientific Officer](https://www.libd.org/keri-martinowich-ph-d-chief-scientific-officer/) - Lieber Institute for Brain Development Appoints Keri Martinowich, Ph.D., as Chief Scientific Officer Baltimore, MD (January 6, 2025) — The Lieber Institute for Brain Development (LIBD) announced the appointment of Keri Martinowich, Ph.D., as Chief Scientific Officer (CSO), marking a major milestone as the Institute enters its fifteenth year of operations and advances its mission
- [STUDY IDENTIFIES POTENTIAL TREATMENT FOR AUTISM SPECTRUM DISORDER](https://www.libd.org/study-identifies-potential-treatment-for-autism-spectrum-disorder/) - BALTIMORE—March 10, 2016—The Lieber Institute for Brain Development (LIBD) released today the results of an innovative study that may lead to a clinical trial within a relatively short time for the treatment of Pitt-Hopkins syndrome (PTHS), a type of autism spectrum disorder. There are currently no medications available to treat the cognitive and behavioral deficits
- [COVERAGE OF THE LIEBER INSTITUTE'S RECENT DISCOVERY OF POTENTIAL NEW TREATMENT FOR AUTISM](https://www.libd.org/coverage-of-the-lieber-institutes-recent-discovery-of-potential-new-treatment-for-autism/) - The Lieber Institute's breakthrough study was recently featured in the Baltimore Sun! Investigators are poised to continue the effort to find new treatments through additional research into Pitt-Hopkins syndrome, a rare form of autism. Read Full Article
- [GRANT ESTABLISHES NEW PARTNERSHIP TO ADVANCE PITT-HOPKINS RESEARCH](https://www.libd.org/grant-establishes-new-partnership-to-advance-pitt-hopkins-research/) - BALTIMORE—July 27, 2016—The Lieber Institute for Brain Development (LIBD) and the Brace Cove Health Fund announce a partnership to advance molecular research on Pitt Hopkins syndrome (PTHS). There are currently no medications available to treat the deficits associated with PTHS, which is characterized by developmental delay, communication deficits, low muscle tone, seizure, constipation and breathing
- [LIBD SCIENTISTS FIND PROMYELINATING DRUGS COULD BENEFIT PITT-HOPKINS PATIENTS](https://www.libd.org/libd-scientists-find-promyelinating-drugs-could-benefit-pitt-hopkins-patients/) - NEW RESEARCH SHOWS PROMYELINATING THERAPIES, INCLUDING TWO EXISTING DRUGS, COULD TREAT RARE CONDITION A new study from the Lieber Institute for Brain Development finds that promyelinating therapies, including two existing drugs, could be beneficial for Pitt-Hopkins Syndrome patients. Pitt-Hopkins syndrome is a rare neurodevelopmental disorder known to produce symptoms similar to those of autism spectrum
- [The Science, and the Humanity, of Giving](https://www.libd.org/the-science-and-the-humanity-of-giving/) - The Science, and the Humanity, of Giving By Daniel R. Weinberger, M.D. CEO & Director, Lieber Institute for Brain Development Every December, we are reminded of the importance of giving. It is a season when people pause, reflect, and often decide to help others in ways both big and small. I’ve spent more than four decades
- [Inside the Habenula: Lieber Institute Researchers Uncover a Hidden Player in Schizophrenia](https://www.libd.org/inside-the-habenula-lieber-institute-researchers-uncover-a-hidden-player-in-schizophrenia/) - About the size of a pea, the habenula serves as a hub connecting key brain systems that regulate motivation, mood, and reward — all of which are disrupted in schizophrenia. Yet until now, the habenula has remained largely invisible to human neuroscience.
- [Tiny Brain Region May Hold Clues to Schizophrenia, Scientists Say](https://www.libd.org/tiny-brain-region-may-hold-clues-to-schizophrenia-scientists-say/) - What the Study Found Scientists have long searched for what goes wrong in the brains of people with schizophrenia. Now, researchers at the Lieber Institute for Brain Development in Baltimore may have found an unexpected piece of the puzzle — in one of the brain’s smallest and least-studied regions, called the habenula. The habenula is
- [Charting the Human Hippocampus: A High-Resolution Transcriptomic Atlas from the Lieber Institute](https://www.libd.org/charting-the-human-hippocampus-a-high-resolution-transcriptomic-atlas-from-the-lieber-institute/) - Scientists at the Lieber Institute have created a detailed map of the human hippocampus - where learning, emotion, and memory live. This work helps unlock the secrets of brain health and mental illness. The human hippocampus (HPC)—central to memory, emotion, and stress regulation—has long been a focal point in neuroscience. Yet, the fine-grained molecular architecture
- [Unlocking the Secrets of the Brain’s Memory Center](https://www.libd.org/unlocking-the-secrets-of-the-brains-memory-center/) - Imagine seeing inside the part of your brain that helps you remember your first kiss, solve a puzzle, or feel calm. That’s what scientists just did! They built the most detailed “GPS map” of the human hippocampus - paving the way for new treatments for Alzheimer’s, depression, and more. Imagine being able to look inside
- [The Amygdala: Secrets Behind Fear, Joy, and Mental Illness](https://www.libd.org/the-amygdala-secrets-behind-fear-joy-and-mental-illness/) - Have You Ever Wondered Why Emotions Hit So Hard? Why does your heart race when you’re scared, or why do certain memories feel charged with emotion? The answer lies in a small, almond-shaped region deep in the brain called the amygdala. The amygdala plays a critical role in processing emotions, forming memories, and responding to
- [Air Pollution & Lewy Body Dementia: New Research Reveals Concerning Link](https://www.libd.org/air-pollution-lewy-body-dementia-new-research-reveals-concerning-link/) - A groundbreaking study published in the journal Science this month has uncovered a significant connection between air pollution and Lewy Body Dementia, the second most common form of dementia after Alzheimer's disease. What the Research Found Researchers from Johns Hopkins University, the Lieber Institute for Brain Development and other partner institutions discovered that exposure to
- [Biotech Leader Dan Browne Joins Board of Directors at the Lieber Institute for Brain Development](https://www.libd.org/biotech-leader-dan-browne-joins-board-of-directors-at-the-lieber-institute-for-brain-development/) - Dan Browne, a longtime advocate for innovation in mental health care, is LIBD's newest board member. Mr. Browne brings more than 30 years of experience as a visionary biotech leader and entrepreneur in the life science industry. His leadership in the development of novel treatments that aim to improve access, speed of relief, and overall outcomes for patients facing the most difficult-to-treat conditions will accelerate the mission and work of LIBD.
- [Lieber Institute for Brain Development Goes All-In on AWS to Develop New Drug Treatments for Brain Diseases](https://www.libd.org/lieber-institute-for-brain-development-goes-all-in-on-aws-to-develop-new-drug-treatments-for-brain-diseases/) - Leveraging the power of the AWS Infrastructure and Services, including Artificial Intelligence (AI), will help scientists rapidly expand drug discovery and bring new treatments to patients and families Baltimore, Maryland (June 10, 2025) — The Lieber Institute for Brain Development (LIBD) is revolutionizing its drug discovery efforts by expanding its technology capabilities on Amazon Web
- [World Schizophrenia Day: A Message of Hope from Our CEO](https://www.libd.org/world-schizophrenia-day-a-message-of-hope-from-our-ceo/) - Every year, May 24 marks World Schizophrenia Day, a time to raise awareness about the brain disorder that ranks among the top 15 causes of disability worldwide, according to the National Institutes of Health. Our Director and CEO Dr. Daniel Weinberger, MD, has devoted his career to the study of schizophrenia and other developmental brain
- [Bytes Behind the Breakthroughs: AI in Brain Research](https://www.libd.org/bytes-behind-the-breakthroughs-ai-in-brain-research/) - Artificial intelligence plays a crucial role in the groundbreaking neuroscience research taking place in the Lieber Institute for Brain Development’s laboratories. But exactly how will deep learning or AI accelerate our scientists’ quest to bring new treatments and diagnostic tools to patients and their families? Lieber Institute Chief Advancement Officer Geoff DeLizzio recently sat down
- [Brain Donor Mom Hosts Conference to Educate Her Community on Mental Health & Substance Use](https://www.libd.org/brain-donor-mom-hosts-conference-to-educate-her-community-on-mental-health-substance-use/) - When Priscilla Agnew-Hines lost her son, Larry Agnew, on March 26, 2020, she knew she wanted to turn his passing into something positive. On March 26, 2025, she got her wish. The date marked the first conference sponsored by Priscilla’s nonprofit, Healthy 2 Connections, aimed at raising awareness about mental illness and substance abuse in
- [Free Webinar April 30: How Does AI Power Mental Health Research?](https://www.libd.org/free-webinar-april-30-how-does-ai-power-mental-health-research/) - Interested in how scientists use AI for medicine? Learn the facts directly from our experts in our free, live webinar on April 30 at noon. Dr. Shizhong Han and Dr. Michael Nagle will share how they’re using cutting-edge AI to accelerate discoveries in mental health and brain aging. Deep-learning tools help them reveal hidden patterns
- [Giulio Pergola Wins International Schizophrenia Research Award](https://www.libd.org/giulio-pergola-wins-international-schizophrenia-research-award/) - CHICAGO, ILLINOIS (March 31, 2025) – Lieber Institute for Brain Development Investigator Dr. Giulio Pergola, PhD, has won the 2025 Research Excellence Award from the Schizophrenia International Research Society, known as SIRS. The Society presented Dr. Pergola with the award at its 2025 Annual Congress in Chicago in March. “I am deeply honored to receive this
- [New AI Model Examines DNA Methylation to Better Understand Mental Illness](https://www.libd.org/new-ai-model-examines-dna-methylation-to-better-understand-mental-illness/) - New AI Model Examines DNA Methylation to Better Understand Mental Illness Jan. 1, 2025 -- New research from the Lieber Institute for Brain Development uses artificial intelligence (AI) to uncover how small changes in our DNA sequence influence a process called DNA methylation. Methylation is a crucial process that regulates gene expression in different types
- [BI and LIBD Advance Development to Treat Cognitive Impairment in Neuropsychiatric Disorders](https://www.libd.org/boehringer-ingelheim-and-libd-advance-development-of-comt-inhibitors-to-treat-cognitive-impairment-in-neuropsychiatric-disorders/) - The Lieber Institute announced the progression toward clinical testing of a unique COMT inhibitor from its collaboration with Boehringer Ingelheim.
- [Ask the Expert: Computers that Cure? AI for Medicine](https://www.libd.org/ask-the-expert-computers-that-cure-ai-for-medicine/) - Could computers cure mental illness? We sat down with an AI data whiz.
- [Ask the CEO: Personalized Mental Health for All](https://www.libd.org/ask-the-ceo-personalized-mental-health-for-all/) - Lieber Institute Founding Director & CEO Dr. Daniel Weinberger describes the importance of diversity in research.
- [2024: A Look Back From Dr. Daniel Weinberger](https://www.libd.org/2024-a-look-back-from-dr-daniel-weinberger/) - A look back at the Lieber Institute's most outstanding accomplishments of 2024 from Dr. Daniel Weinberger, our director and CEO.
- [LIBD Wins Amazon Web Services IMAGINE Grant for Nonprofits](https://www.libd.org/libd-wins-amazon-web-services-imagine-grant-for-nonprofits/) - Baltimore, Maryland (Dec. 3, 2024) — The Lieber Institute for Brain Development has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant, a public grant opportunity open to registered charities in the United Kingdom and Ireland and registered 501(c) nonprofit organizations in the United States who are using technology to
- [Watch: Free Recorded Webinar on the Mental Health Crisis](https://www.libd.org/join-us-for-a-free-live-webinar-on-the-mental-health-crisis/) - Did you miss our free, live webinar on Oct. 23, The Mental Health Crisis: Why Are New Treatments So Hard to Find and What Can We Do About It? Now you can watch the recording. In this timely webinar, two leading experts in drug development and brain research from the Lieber Institute for Brain Development
- [September is Suicide Prevention Month, and the Lieber Institute is Striving for Answers](https://www.libd.org/september-is-suicide-prevention-month-and-the-lieber-institute-is-striving-for-answers/) - September is Suicide Prevention Month, and for good reason. Suicide is a leading cause of death in the United States. In 2022, more than 49,000 people died by suicide, according to the Centers for Disease Control and Prevention. That’s one death every 11 minutes. A short, intense moment of suicidal active crisis can take a
- [LIBD Scientists Find Genes Adjacent to Schizophrenia Risk Genes Carry Their Own Risk](https://www.libd.org/8125-2/) - BALTIMORE, MD. — Sept. 4, 2024 — Finding the genes that turn on and off to cause disease isn’t always as simple as in Huntington’s disease, in which one mutation in a single gene causes the rare disorder. Schizophrenia, for example, results from genetic risk spread throughout the genome. That’s why, for 14 years, Lieber
- [AANRI Leaders Discuss Diversity in Neuroscience with Research!America](https://www.libd.org/aanri-leaders-discuss-diversity-in-neuroscience-with-researchamerica/)
- [African Ancestry Neuroscience Research Initiative's 1st Study Identifies Key Genes in the Brain that Account for Higher Rates of Some Brain Disorders in Black Americans](https://www.libd.org/first-study-from-the-african-ancestry-neuroscience-research-initiative-identifies-key-genes-in-the-brain-that-account-for-higher-rates-of-some-brain-disorders-in-black-americans/) - BALTIMORE, Md. (May 20, 2024) – Scientists seeking to counter the neglect of African Americans in neuroscience research have found evidence that genetic ancestry is responsible for the increased prevalence of certain neurological disorders, such as Alzheimer’s disease and stroke, and decreased prevalence of others, including Parkinson’s disease, in Black Americans, according to new research
- [Lieber Institute Scientists Lead Significant PsychENCODE Research in Science](https://www.libd.org/lieber-institute-scientists-lead-significant-psychencode-research-in-science/) - The journal Science in May published a raft of papers produced by the PsychENCODE Consortium, and Lieber Institute scientists played a crucial role on three of the nine articles. The National Institutes of Health founded the PsychENCODE project in 2015 as a multidisciplinary initiative to study the molecular basis of neuropsychiatric diseases in hopes of
- [LIBD In the News: Dr. Weinberger in STAT on Living Brain Biopsies](https://www.libd.org/libd-in-the-news-dr-weinberger-in-stat-on-living-brain-biopsies/) - Dr. Daniel Weinberger commented on living brain biopsies for an article in STAT about biopsies taken from deep brain stimulation (DBS) patients at Mount Sinai in Manhattan. Lieber Institute researchers led by Dr. Leonardo Collado Torres released as a preprint a rebuttal paper addressing Mount Sinai's Living Brain Project in the fall of 2023. In
- [In Memoriam: Dr. Herbert Pardes, Lieber Institute Founding Board Chair](https://www.libd.org/in-memoriam-dr-herbert-pardes-lieber-institute-founding-board-chair/) - A statement from Lieber Institute for Brain Development Director and CEO Dr. Daniel Weinberger on the passing of Dr. Herbert Pardes: I am very sad to share the news that Dr. Herbert Pardes, founding chair of the Lieber Institute for Brain Development’s Board of Directors, passed away on April 30. Dr. Pardes was a dear
- [LIBD Researchers Develop Possible Scoring System for Schizophrenia Symptoms](https://www.libd.org/libd-researchers-develop-possible-scoring-system-for-schizophrenia-symptoms/) - Psychiatric diagnoses are notoriously imprecise. Patients with the same diagnosis typically differ from one another in many respects, including in their particular symptoms as well as in measurements made with brain imaging approaches. This variability is a tough challenge for scientists trying to develop novel, more personalized treatments. In schizophrenia, results from genetic studies have
- [The Rose Window: A Limited Series on Human Connection & Mental Health](https://www.libd.org/the-rose-window-a-limited-series-on-human-connection-mental-health/) - Ever wanted to hear, directly from the experts, how brain diseases such as schizophrenia, bipolar disorder and depression develop in the brain? What are the most effective treatments for mental illness? What will the science of mental health and mental illness look like in the future? The Lieber Institute for Brain Development has launched a
- [Look Again: A Podcast Featuring Dr. Dan Weinberger](https://www.libd.org/look-again-a-podcast-featuring-dr-dan-weinberger/) - Have you wondered if a cure for mental illness lies just beyond the horizon? Dr. Daniel Weinberger, Director and CEO of the Lieber Institute for Brain Development, discussed the possibilities on the podcast Look Again, produced by the British Columbia Schizophrenia Society and its partners. Listen to his episode, "Hope on the Horizon," to learn
- [Watch: Diversity in Discovery | The Story of the African Ancestry Neuroscience Research Initiative](https://www.libd.org/watch-diversity-in-discovery-the-story-of-the-african-ancestry-neuroscience-research-initiative/) - Watch a recording of our live stream kicking off Black History Month with a discussion of diversity, equity and inclusion in neuroscience, featuring our own experts on the subject: Dr. Kafui Dzirasa, M.D., Ph.D., Advisor to the African Ancestry Neuroscience Research Initiative, Professor at Duke University School of Medicine, and Howard Hughes Medical Institute Investigator
- [Join Our Black History Month Live Stream](https://www.libd.org/join-our-black-history-month-live-stream/) - Join us at noon on Feb. 1 at aanri.org/live as we kick off Black History Month with a live-streamed discussion of diversity, equity and inclusion in neuroscience, featuring our own experts on the subject: Dr. Kafui Dzirasa, M.D., Ph.D., an advisor to the African Ancestry Neuroscience Research Initiative, a professor at Duke University School of
- [LIBD Researchers Present at Society for Neuroscience's Annual Conference](https://www.libd.org/libd-researchers-present-at-society-for-neurosciences-neuroscience-2023-conference/) - The SFN's annual conference, Neuroscience 2023, starts Saturday, Nov. 11, and the Lieber Institute for Brain Development will be an integral part of the program.
- [Dr. Keri Martinowich Honored with ACNP's Efron Research Award](https://www.libd.org/dr-keri-martinowich-honored-with-acnps-efron-research-award/) - The American College of Neuropsychopharmacology has honored Lieber Institute Lead Investigator Keri Martinowich, Ph.D., with the 2023 Daniel H. Efron Research Award.
- [Scientists Simulate Mini-Brains to Discover Early Developmental Issues in Brains of People with Schizophrenia](https://www.libd.org/scientists-simulate-mini-brains-to-discover-early-developmental-issues-in-brains-of-people-with-schizophrenia/) - Researchers from the Lieber Institute for Brain Development have used organoids to identify a developmental problem found early in life in the brains of people who later have schizophrenia.
- [Lieber Institute Researchers Discover Biomarker in Mice to Aid in Developing Attention-Enhancing Drugs](https://www.libd.org/lieber-institute-researchers-discover-biomarker-in-mice-to-aid-in-developing-attention-enhancing-drugs/) - Scientists at the Lieber Institute for Brain Development may have identified in mice a key mechanism of attention that could help develop attention-enhancing drugs.
- [BullFrog AI Announces Strategic Partnership with Lieber Institute for Brain Development](https://www.libd.org/bullfrog-ai-announces-strategic-partnership-with-lieber-institute-for-brain-development/) - GAITHERSBURG, Md., Sept. 13, 2023 -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced a three-year global strategic partnership with the Lieber Institute for Brain Development (LIBD), a non-profit
- [LIBD Research Uncovers Breakthrough in Predicting Risk for Schizophrenia](https://www.libd.org/libd-research-uncovers-breakthrough-in-predicting-risk-for-schizophrenia/) - A novel approach to existing functional neuroimaging datasets led to a breakthrough in understanding genetic and clinical risk for schizophrenia in the context of how brain regions communicate with each other. The research was published in PNAS—read the paper here. Researchers, including Lieber Institute Investigator Giulio Pergola, Ph.D., and others from the University of Bari
- [LIBD CEO Named PennMedicine Distinguished Graduate](https://www.libd.org/libd-ceo-named-pennmedicine-distinguished-graduate/) - Lieber Institute CEO and Director Dr. Daniel Weinberger was honored by his alma mater, the Perelman School of Medicine at the University of Pennsylvania, with the 2023 Distinguished Graduate Award. Dr. L. Scott Levin, chair of the PennMedicine Department of Orthopaedic Surgery, presented Dr. Weinberger with his award. Read more.
- [NEW STUDY FINDS THE PLACENTA, NOT ONLY THE BRAIN, PLAYS A CENTRAL ROLE IN GENETIC RISK OF SCHIZOPHRENIA](https://www.libd.org/new-study-finds-the-placenta-not-only-the-brain-plays-a-central-role-in-genetic-risk-of-schizophrenia/) - NEW STUDY FINDS THE PLACENTA, NOT ONLY THE BRAIN, PLAYS A CENTRAL ROLE IN GENETIC RISK OF SCHIZOPHRENIA Future Prevention Strategies Could Target Treatment of the Placenta BALTIMORE, Md. (May 15, 2023) – More than 100 genes linked to the risk of schizophrenia seem to cause illness because of their role in the placenta rather
- [SCHIZOPHRENIA TAKES A VILLAGE](https://www.libd.org/schizophrenia-takes-a-village/) - SCHIZOPHRENIA RISK GENES NEED ENVIRONMENT OF PARTNER GENES TO DEVELOP ILLNESS, NEW LIBD STUDY SHOWS BALTIMORE, Md. (April 14, 2023) – Modern medical research seeks to understand how genes and the environment converge on risk for most common medical disorders, from heart attack and asthma to schizophrenia and PTSD. When we think of the environment,
- [LIBD SCIENTISTS EXAMINE HOW SARS-CoV-2 INFECTION DURING PREGNANCY AFFECTS  A CHILD’S RISK FOR NEURODEVELOPMENTAL DISORDERS](https://www.libd.org/libd-scientists-examine-how-sars-cov-2-infection-during-pregnancy-affects-a-childs-risk-for-neurodevelopmental-disorders/) - Study Led by the Lieber Institute for Brain Development to Examine Molecular Risk Factors Found in the Placenta Research Funded with $3 Million Grant from the National Institutes of Health BALTIMORE, Md. (March 13, 2023) – Scientists led by the Lieber Institute for Brain Development are studying how a mother’s SARS-CoV-2 infection during pregnancy affects
- [The Nation’s First African American Neuroscience Research Initiative](https://www.libd.org/the-nations-first-african-american-neuroscience-research-initiative/) - Baltimore's African-American Clergy and Brain Research Institute Establish the Nation's First African Ancestry Neuroscience Research Initiative Addressing Health and Neuroscience Research Disparities
- [LIBD's African Ancestry Research in the Baltimore Banner](https://www.libd.org/libds-african-ancestry-research-in-the-baltimore-banner/) - The Baltimore Banner ran an article on Feb. 27 featuring the Lieber Institute for Brain Development's new grant from the Chan Zuckerberg Initiative to fund its African Ancestry Neuroscience Research Initiative. Read more in the Baltimore Banner.
- [Racial Disparities in Science: A Podcast](https://www.libd.org/racial-disparities-in-science-a-podcast/) - The podcast It Starts With Us featured Lieber Institute Director & CEO Dr. Daniel Weinberger and African Ancestry Neuroscience Research Initiative head Rev. Al Hathaway.
- [LIBD RECEIVES $1M FROM CHAN ZUCKERBERG INITIATIVE TO FOSTER DIVERSITY IN NEUROSCIENCE](https://www.libd.org/libd-receives-1m-from-chan-zuckerberg-initiative-to-foster-diversity-in-neuroscience/) - BALTIMORE, Md. (February 27, 2023) – The Lieber Institute for Brain Development has received a $1 million, two-year grant from the Chan Zuckerberg Initiative to support the work of the African Ancestry Neuroscience Research Initiative (AANRI) to promote racial equity throughout the field of neuroscience. AANRI began in 2019 as a collaboration between African American
- [New Study Finds Genes and Air Pollution Multiply Healthy People’s  Risk of Depression](https://www.libd.org/new-study-finds-genes-and-air-pollution-multiply-healthy-peoples-risk-of-depression/) - Neuroscientists at the Lieber Institute for Brain Development and at Peking University in Beijing reveal how air pollution and genes join forces to affect brain circuitry, increasing depression risk
- [New study provides first look at gene expression in brains of people with bipolar disorder](https://www.libd.org/new-study-provides-first-look-at-gene-expression-in-brains-of-people-with-bipolar-disorder/) - In a comprehensive study involving one of the largest-ever samples of post-mortem brains, scientists at the Lieber Institute have pinpointed significant differences in gene expression in two specific regions of the brains of hundreds of patients who had bipolar disorder.
- [neuroDEVELOPMENTS: Can Adult Humans Produce New Neurons?](https://www.libd.org/neurodevelopments-can-adult-humans-produce-new-neurons/) - The latest issue of the newsletter neuroDEVELOPMENTS examines whether adult human brains can produce new neurons.
- [Solving the Dopamine Riddle](https://www.libd.org/solving-the-dopamine-riddle/) - A new LIBD study pinpoints the genetic mechanism linking dopamine to schizophrenia.
- [World Mental Health Day 2022](https://www.libd.org/world-mental-health-day-2022/) - Lieber Institute scientists are striving for solutions for mental illness.
- [NEW STUDY: DEEP LEARNING HELPS UNCOVER GENETICS OF PSYCHIATRIC DISORDERS](https://www.libd.org/new-study-deep-learning-helps-uncover-genetics-of-psychiatric-disorders/) - Lieber Institute scientists are using artificial intelligence to learn more about how changes in the genetic code can impact psychiatric disorders such as schizophrenia.
- [LIBD IN THE NEWS: BioWorld](https://www.libd.org/libd-in-the-news-bioworld/) - Lieber Institute researchers have uncovered the mutagenesis processes that take place throughout life, from development to senescence.
- [Ten Years On: The Lieber Institute After A Decade](https://www.libd.org/ten-years-on-the-lieber-institute-after-a-decade/) - In a grand rounds presentation at the Johns Hopkins University School of Medicine, Dr. Daniel Weinberger, Lieber Institute director and CEO, reflects on the first decade of the Institute's operations.
- [On the Passing of Country Star Naomi Judd](https://www.libd.org/on-the-passing-of-naomi-judd/) - We were deeply saddened to hear of the passing of singer and songwriter Naomi Judd, a dear friend of the Lieber Institute for Brain Development.
- [LIBD IN THE NEWS: STAT and the Boston  Globe](https://www.libd.org/libd-in-the-news-stat-and-the-boston-globe/) - Rev. Al Hathaway, CEO of the African Ancestry Research Initiative, writes about his journey to biomedical research advocacy.
- [New Study Finds Neurons Derived from Stem Cells Predict Psychosis and Cognitive Deficits in Individuals with Schizophrenia](https://www.libd.org/new-study-finds-neurons-derived-from-stem-cells-predict-psychosis-and-cognitive-deficits-in-individuals-with-schizophrenia/) - Findings open door to personalized medicine, with the potential to predict the onset of schizophrenia — and the severity of symptoms — well before the first psychotic episode.
- [LIEBER INSTITUTE FOR BRAIN DEVELOPMENT PUBLICATION CHOSEN FOR THE AMERICAN JOURNAL OF PSYCHIATRY YEAR IN REVIEW](https://www.libd.org/lieber-institute-for-brain-development-publication-chosen-for-the-american-journal-of-psychiatry-year-in-review/) - Robert Freedman, M.D., editor of the American Journal of Psychiatry (AJP) has selected a paper by Rebecca Birnbaum, M.D., and colleagues, as a noteworthy paper of 2014 in a year-end review, featuring the paper as "particularly interesting and important." The paper, published in AJP in July, reports findings from an investigation as to whether the
- [Boehringer Ingelheim and The Lieber Institute for Brain Development to Collaborate to Develop Centrally Acting COMT Inhibitors for Treatment of Neuropsychiatric Disorders](https://www.libd.org/boehringer-ingelheim-and-the-lieber-institute-for-brain-development-to-collaborate-to-develop-centrally-acting-comt-inhibitors-for-treatment-of-neuropsychiatric-disorders/) - • Through the partnership with the Lieber Institute, Boehringer Ingelheim obtains access to preclinical pipeline candidates of a potential first-in-class approach for the symptomatic treatment of neuropsychiatric disorders, including schizophrenia. • The new collaboration further expands Boehringer Ingelheim’s circuitry-based approach to precision psychiatry and solidifies the company’s commitment to provide better treatments for patients living
- [Brown Capital Management and State of Maryland Commit $2.25 Million to Nation’s First African Ancestry Neuroscience Research Initiative](https://www.libd.org/brown-capital-management-and-state-of-maryland-commit-2-25-million-to-nations-first-african-ancestry-neuroscience-research-initiative/) - Major Funding, Partnership with Morgan State University Will Catalyze Effort to Address Health and Neuroscience Research Disparities
- [LIBD in the News: NPR's All Things Considered](https://www.libd.org/libd-in-the-news-nprs-all-things-considered/) - The full story from Jon Hamilton aired September 24, 2020.
- [LIBD in the News: WYPR](https://www.libd.org/libd-in-the-news-wypr/)
- [LIBD in the News: Baltimore Business Journal](https://www.libd.org/libd-in-the-news-baltimore-business-journal/)
- [A statement from the Lieber Institute](https://www.libd.org/a-statement-from-the-lieber-institute/) - Black Lives Matter June 19, 2020
- [In Memoriam: Steve Lieber](https://www.libd.org/in-memoriam-steve-lieber/) - In Memoriam: Steve Lieber March 31, 2020
- [New study shows role of specific cell populations in genetic risk for schizophrenia](https://www.libd.org/new-study-shows-role-of-specific-cell-populations-in-genetic-risk-for-schizophrenia/)
- [LIBD in the News: NPR](https://www.libd.org/libd-in-the-news-npr/) - Full story from Jon Hamilton, published online in February 3, 2020.
- [New Study Links Autism to a Specific Cell That Produces Insulation Critical to the Early Wiring of the Brain](https://www.libd.org/new-study-links-autism-to-a-specific-cell-that-produces-insulation-critical-to-the-early-wiring-of-the-brain/) - New Study Links Autism to a Specific Cell That Produces Insulation Critical to the Early Wiring of the Brain Postmortem brain tissue from autism patients reveals impairment of “myelination” process that ensures neurons can communicate; efforts now turn to evaluating drugs that could correct the problem
- [LIBD in the News: Spectrum News](https://www.libd.org/libd-in-the-news-spectrum-news/) - Full story was written by Nicholette Zeliadt and published online in Spectrum News on October 23, 2019
- [LIBD in the News: The Washington Post](https://www.libd.org/libd-in-the-news-the-washington-post/) - Full story was written by Emily Mullin and published online in The Washington Post on April 6, 2019
- [LIBD in the News: Sinclair Broadcast Group](https://www.libd.org/libd-in-the-news-sinclair-broadcast-group/) - Segment was produced by Joce Sterman and Alex Brauer and published by WJLA on December 19, 2019.
- [LIBD in the News: PBS NewsHour](https://www.libd.org/libd-in-the-news-pbs-newshour/) - This segment was published by PBS NewsHour on October 30, 2019.
- [Abell Foundation Awards Grant to African American Neuroscience Research Initiative for Critical Program Support](https://www.libd.org/abell-foundation-awards-grant-to-african-american-neuroscience-research-initiative-for-critical-program-support/) - Abell Foundation Awards Grant to African American Neuroscience Research Initiative for Critical Program Support U.S. Senate Recognizes Longstanding Disparity in Neuroscience Research and Urges Partnerships to Ensure African Americans Are Represented in Neuroscience Research
- [Daniel Weinberger Receives National Academy of Medicine’s Sarnat Award](https://www.libd.org/daniel-weinberger-receives-national-academy-of-medicines-sarnat-award/) - Daniel Weinberger Receives National Academy of Medicine’s Sarnat Award for His Pioneering Research on Developmental Origins of Schizophrenia
- [LIEBER INSTITUTE ANNOUNCES CONSORTIUM TO IDENTIFY HOW GENES BUILD A BRAIN WITH THE GOAL OF DEVELOPING TREATMENTS FOR BRAIN DISORDERS](https://www.libd.org/lieber-institute-announces-consortium-to-identify-how-genes-build-a-brain-with-the-goal-of-developing-treatments-for-brain-disorders/) - The Lieber Institute for Brain Development (LIBD) and pharmaceutical companies Astellas, Eli Lilly and Company, Lundbeck, Pfizer Inc. and Roche are participating in an early-stage research consortium to analyze RNA, the genomic and epigenetic data obtained from human brains. “Our goal in creating this collaboration with the private industry is to speed discoveries that may
- [Placenta Symposium 2018 Recap](https://www.libd.org/placenta-symposium-2018-recap/) - Over 320 Registrants for Inaugural One-Day Symposium Event, Translating Placental Biology into Child Development
- [CRACKING THE CODE OF BRAIN DEVELOPMENT](https://www.libd.org/cracking-the-code-of-brain-development/) - With a unique, multi-faceted approach, researchers at the Lieber Institute for Brain Development (LIBD) have quantified the effect of previously unidentified anomalies in genetic expression that determine how the human brain develops from its earliest stages. Their work, published online December 15th in Nature Neuroscience, offers a novel technique for identifying biological markers in brain
- [Scientists Report Insight that Could Produce New Treatment Targets for Schizophrenia](https://www.libd.org/scientists-report-insight-that-could-produce-new-treatment-targets-for-schizophrenia/) - Scientists Uncover Disharmony in Genes Expressed across Brain Regions in Schizophrenia Study is first to find that in people with schizophrenia, genes may function differently in different parts of the brain which fail to coordinate with each other.
- [LIBD in the News: The Baltimore Sun](https://www.libd.org/libd-in-the-news-the-baltimore-sun/) - Full Story was Published in The Baltimore Sun on March 29, 2019
- [LIBD in the News: The New York Times](https://www.libd.org/libd-in-the-news-the-new-york-times/) - Full Story was Published in The New York Times on December 3, 2018.
- [Naomi Judd, Dr. Weinberger Offer Hope and a Call-to-Action During Mental Illness Awareness Week](https://www.libd.org/naomi-judd-dr-weinberger-offer-hope-and-a-call-to-action-during-mental-illness-awareness-week/) - This content originally appeared on People.com, October 02, 2018.
- [Nomination Period Begins for 2019 Constance Lieber Prize for Innovation in Developmental Neuroscience](https://www.libd.org/2019-constance-lieber-prize-for-innovation-in-developmental-neuroscience-now-accepting-nominations/) - The Lieber Institute for Brain Development Announces Nomination Period for the 2019 Constance Lieber Prize for Innovation in Developmental Neuroscience The biennial award honors the legacy of the Institute’s founder, Constance Lieber
- [New Insights into the Effects of Tobacco Use During Pregnancy Include Links to Autism Spectrum Disorder](https://www.libd.org/new-insights-into-the-effects-of-tobacco-use-during-pregnancy-include-links-to-autism-spectrum-disorder/)
- [The promise of personalized medicine is not for everyone](https://www.libd.org/the-promise-of-personalized-medicine-is-not-for-everyone/)
- [Dr. Hyde on Australia Radio](https://www.libd.org/dr-hyde-on-australia-radio/) - Last month our Chief Medical Officer, Dr. Hyde, made a visit to Australia where he caught up with ABC Radio to discuss LIBD's human brain repository and the importance of studying the brain to find new treatments for neuropsychiatric disorders. Listen Here: ABC Radio Australia
- [Dr. Weinberger, University of Oxford Visiting Professor, Gives Litchfield Lecture](https://www.libd.org/dr-weinberger-university-of-oxford-visiting-professor-gives-litchfield-lecture/)
- [LIBD in the News: CERO Kari Stoever Earns Bronze at Worlds](https://www.libd.org/libd-in-the-news-cero-kari-stoever-earns-bronze-at-worlds/)
- [LIBD Awards First 'Mission Forward' Grants](https://www.libd.org/libd-awards-first-mission-forward-grants/) - Mission Forward Grants July 3, 2018 Baltimore, MD
- [Extreme stress in childhood is toxic to your DNA](https://www.libd.org/extreme-stress-in-childhood-is-toxic-to-your-dna/)
- [New study finds placenta health affects risk of schizophrenia](https://www.libd.org/new-study-finds-placenta-health-affects-risk-of-schizophrenia/)
- [Video Abstract: Brain, A Journal of Neurology](https://www.libd.org/video-abstract-brain-a-journal-of-neurology/) - "Schizophrenia polygenic risk score predicts mnemonic hippocampal activity" Brain: A Journal of Neurology Published on Feb 20, 2018 Authors: Qiang Chen, Gianluca Ursini, Adrienne L Romer, Annchen R Knodt, Karleigh Mezeivtch, Ena Xiao, Giulio Pergola, Giuseppe Blasi, Richard E Straub, Joseph H Callicott, Karen F Berman, Ahmad R Hariri, Alessandro Bertolino, Venkata S Mattay, and
- [MAJOR NEW STUDY REWRITES THE NATURE V. NURTURE DEBATE ABOUT SCHIZOPHRENIA](https://www.libd.org/major-new-study-rewrites-the-nature-v-nurture-debate-about-schizophrenia/) - BALTIMORE—Nov. 30, 2015—The Lieber Institute for Brain Development (LIBD) released today the results of a study that shed new insights on the nature versus nurture interplay in schizophrenia. Findings from one of the largest studies of postmortem human brain tissue suggest that environmental influences during the prenatal period cause brain changes associated with schizophrenia, but that environmental
- [LIBD in the News: Greater Baltimore Committee](https://www.libd.org/libd-in-the-news-greater-baltimore-committee/) - LIBD in the News February 3, 2018 / Greater Baltimore Committee As the NFL wraps another season, Donald C. Fry, President and CEO of the Greater Baltimore Committee, takes a closer look at the Lieber Institute’s research that could potentially help players (and others) living with CTE. The piece, published in Medium on February 3rd,
- [The Lieber Institute for Brain Development Discovers an Innovative Approach to Improve Genomic Data in the Human Brain](https://www.libd.org/the-lieber-institute-for-brain-development-discovers-an-innovative-approach-to-improve-genomic-data-in-the-human-brain/)
- [Lieber Institute and UND SMHS Partner to Expand the Largest Human Brain Repository](https://www.libd.org/lieber-institute-and-und-smhs-partner-to-expand-the-largest-human-brain-repository/)
- [Historic Partnership Aims to Accelerate the Discovery of Novel Treatment Targets for Posttraumatic Stress Disorder (PTSD)](https://www.libd.org/historic-partnership-aims-to-accelerate-the-discovery-of-novel-treatment-targets-for-posttraumatic-stress-disorder-ptsd/)
- [Lieber Institute for Brain Development Partners with BullFrog AI](https://www.libd.org/lieber-institute-for-brain-development-partners-with-bullfrog-ai/)
- [LIBD in the News: National Geographic Explorer](https://www.libd.org/libd-in-the-news-national-geographic-explorer/) - The National Geographic Channel’s documentary series, Explorer, featured several segments filmed at the Lieber Institute in Season 10, Episode 14 about new treatments for mental illness and the mission to understand the most complex human organ – the brain. In the episode, Dr. Weinberger is featured discussing the history & current state of brain disorder
- [LIBD in the News: BBC World News](https://www.libd.org/libd-in-the-news-bbc-world-news/) - LIBD in the News January 4, 2018 / BBC World News BBC World News featured a story on the Lieber Institute during their broadcast on Wednesday, January 3rd. The segment, which reached an estimated BBC audience of 372 million viewers worldwide, highlights our mission to translate genetic insights and the underlying biological causes of mental illness
- [It’s Time to Stop Hiding Mental Illness](https://www.libd.org/its-time-to-stop-hiding-mental-illness/) - Same Voice, New Message: Naomi Judd talks depression and the need for greater awareness and new treatments Naomi Judd, Daniel R. Weinberger December 5, 2017
- [The Human Brain: the Final Biological Frontier](https://www.libd.org/the-human-brain-the-final-biological-frontier/) - Daniel R. Weinberger CEO & Director November 2, 2017
- [Former NFL Player Donté Stallworth Talks Concussions at the Lieber Institute](https://www.libd.org/former-nfl-player-donte-stallworth-talks-concussions-at-the-lieber-institute/) - Earlier this year, former NFL player Donté Stallworth paid a visit to LIBD for a tour of the Institute and Q&A session with Director and CEO Dr. Weinberger. The conversation explored the status of brain injury in professional and college athletics, and how we might work together to raise awareness around this issue and the importance of
- [LIBD Welcomes Country Music Singer and Songwriter Naomi Judd](https://www.libd.org/libd-welcomes-country-music-singer-and-songwriter-naomi-judd/)
- [The Lieber Institute for Brain Development Establishes the World's Largest Posttraumatic Stress Disorder Postmortem Brain Repository](https://www.libd.org/the-lieber-institute-for-brain-development-establishes-the-worlds-largest-posttraumatic-stress-disorder-postmortem-brain-repository/)
- [Lieber Institute for Brain Development Announces New Website Launch](https://www.libd.org/lieber-institute-for-brain-development-announces-new-website-launch/)
- [LIBD and 23andMe Partner to Find New Treatments for Brain Disorders](https://www.libd.org/libd-and-23andme-partner-to-find-new-treatments-for-brain-disorders/) - LIBD and 23andME, Inc. have formed a partnership to discover new therapies for common behavioral disorders. The goal and focus of the partnership to translate clinical genetic associations in the unique 23andMe program into biological mechanisms in human brain underlying these disorders, which will lead to the discovery of novel therapeutic targets. As part of
- [LIBD DONATES COMPUTERS TO EAST BALTIMORE ELEMENTARY SCHOOL](https://www.libd.org/libd-donates-computers-to-east-baltimore-elementary-school-4/) - Students from William Paca Elementary, located just down the street in East Baltimore, welcomed the Lieber Institute staff on Wednesday, November 16th to receive in donation computers previously idle at the Institute. The Institute staff unloaded computers before joining in games with students and teachers as part of the school’s activities for American Education Week.
- [FORMER NFL WIDE RECEIVER DONTÉ STALLWORTH VISITS LIBD](https://www.libd.org/former-nfl-wide-receiver-donte-stallworth-visits-libd/) - Donté Stallworth, a 10-year veteran of the NFL, paid a visit to LIBD February 24th for a tour of the Institute and Q&A session with Director and CEO Dr. Weinberger. The conversation explored the status of brain injury in professional and college athletics, and how we might work together to raise awareness around this issue and
- [UNLOCKING THE HUMAN BRAIN FOR 21ST CENTURY CURES](https://www.libd.org/unlocking-the-human-brain-for-21st-century-cures/) - KALAMAZOO, MI—March 6, 2017—Research experts from the Lieber Institute for Brain Development (LIBD) and Western Michigan University - Homer Stryker M.D. School of Medicine (WMed), along with the Honorable Fred Upton, U.S. House of Representatives, convened last month for a special event at the WMed campus. The event, “Unlocking the Human Brain for 21st Century
- [2017 CONSTANCE LIEBER PRIZE FOR INNOVATION IN DEVELOPMENTAL NEUROSCIENCE AWARDED TO JOSEPH GLEESON, M.D.](https://www.libd.org/2017-constance-lieber-prize-for-innovation-in-developmental-neuroscience-awarded-to-joseph-gleeson-m-d/) - BALTIMORE, MD—May 3, 2017— The Lieber Institute for Brain Development (LIBD), an affiliate of the Johns Hopkins University School of Medicine, today announced the inaugural recipient of the Constance Lieber Prize for Innovation in Developmental Neuroscience, a new prize in memory of Constance Lieber. The 2017 Constance Lieber Prize for Innovation in Developmental Neuroscience will
- [SENATOR BEN CARDIN VISITS LIEBER INSTITUTE](https://www.libd.org/senator-ben-cardin-visits-lieber-institute/) - Senator Ben Cardin stopped by the Lieber Institute (LIBD) on Friday, April 26th, to learn more about the work we are doing to better understand the human brain. The Senator took a tour of the Institute, which included a scientific demonstration in the lab. He joined LIBD CEO and Director, Dr. Daniel R. Weinberger and
- [CONGRESSMAN CHRIS VAN HOLLEN VISITS LIEBER INSTITUTE](https://www.libd.org/congressman-chris-van-hollen-visits-lieber-institute/) - Congressman Chris Van Hollen joined the Lieber Institute staff to learn more about the work we are doing to better understand the human brain. The Congressman took a tour of our offices, including a lab demonstration and a stop in the drug discovery lab. He also joined Lieber CEO and Director, Dr. Daniel R. Weinberger,
- [MIT TECHNOLOGY REVIEW LOOKS INSIDE LIBD'S PTSD BRAIN COLLECTION](https://www.libd.org/mit-technology-review-looks-inside-libds-ptsd-brain-collection/) - The MIT Technology Review takes a closer look at our PTSD brain repository, the largest collection post-mortem brains with a known PTSD diagnosis, and its essential role in understanding PTSD to uncover new targets for drug discovery. Read Full Article in MIT Technology Review
- [LIEBER INSTITUTE COLLABORATION LEADS TO SUCCESSFUL GROWTH OF MINI HUMAN BRAINS](https://www.libd.org/lieber-institute-collaboration-leads-to-successful-growth-of-mini-human-brains/) - A group of scientists across several institutions, including the Lieber Institute, made news last week when they turned a corner in their two-year long research project, successfully growing human ‘mini-brains’ in the lab. Development of these ‘mini-brains’ in the lab was possible through collaboration between scientists at Duke-NUS Medical School, the Genome Institute of Singapore
- [SCIENCE HIGHLIGHTED THE OPENING OF THE LIEBER INSTITUTE IN 2010](https://www.libd.org/science-highlighted-the-opening-of-the-lieber-institute-in-2010/) - Dream Team Plans a Blitz on Schizophrenia Jocelyn Kaiser With help from philanthropists, they are launching an institute that will look for treatments by probing early brain development for the origins of mental illness. The nonprofit Lieber Institute for Brain Development will be led by Daniel Weinberger {formerly} of the National Institute of Mental Health.
- [DR. DANIEL WEINBERGER HOLDS Q&A WITH NATURE'S ALISON ABBOTT](https://www.libd.org/dr-daniel-weinberger-holds-qa-with-natures-alison-abbott/) - CEO Dr. Daniel Weinberger holds a Q&A with writer Alison Abbott from Nature, discussing the founding and mission of the Lieber Institute in the September issue: "A Radical Approach to Mental Illness"
- [NEW SEQUENCING TECHNOLOGY IN GENOMEWEB / AGBT VIDEO](https://www.libd.org/new-sequencing-technology-in-genomeweb-agbt-video/) - Dr. Yuan Gao, leader of the Bioinformatics, Genetics, and Epigenetics group at the Lieber Institute, offers his unique perspective on exciting new developments in sequencing technology in this short video from the 2012 Advances in Genome Biology and Technology (AGBT) meeting. You can watch the video here: http://www.genomeweb.com/videos/agbt-2012
- [NEW GENE VARIANT CONFERS INCREASED RISK OF PARKINSON'S DISEASE](https://www.libd.org/new-gene-variant-confers-increased-risk-of-parkinsons-disease/) - In collaboration with physicists and systems biologists from Biocant, University of Combra and Catholic University of America, Drs. Yuan Gao and Joo Heon Shin at the Lieber Institute identified a rare, coding, non-synonymous SNP variant in the DZIP1 gene that confers increased susceptibility to Parkinson's disease.
- [ASTELLAS PHARMACEUTICALS-LIEBER INSTITUTE COLLABORATIVE RESEARCH STUDIES](https://www.libd.org/astellas-pharmaceuticals-lieber-institute-collaborative-research-studies/) - The LIBD in Baltimore, MD and Astellas Research Institute of America LLC (ARIA), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. located in Skokie, Illinois, are joining together in a research program to identify novel drug targets by studying gene expression profiles from patients with schizophrenia and bipolar disorder. Lieber Institute for Brain Development (LIBD)
- [USE OF POSTMORTEM HUMAN DURA MATER AND SCALP FOR DERIVING HUMAN FIBROBLAST CULTURES](https://www.libd.org/use-of-postmortem-human-dura-mater-and-scalp-for-deriving-human-fibroblast-cultures/) - Lieber Institute researchers, in collaboration with colleagues at the National Institute of Mental Health, have successfully cultured fibroblasts from dura and scalp of postmortem brain donors. These fibroblasts in turn can be converted into iPS cells for additional research into the mechanisms of neurological and psychiatric disorders. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0045282
- [HUMAN CADAVER BRAINS MAY PROVIDE NEW STEM CELLS](https://www.libd.org/human-cadaver-brains-may-provide-new-stem-cells/) - "We were able to culture living cells from deceased individuals on a larger scale than ever done before," researcher Thomas Hyde, a neuroscientist, neurologist and Chief Operating Officer at the Lieber Institute for Brain Development in Baltimore, told LiveScience. http://www.livescience.com/24005-human-cadaver-brains-stem-cells.html
- [COULD THE STRESS OF CITY LIFE BE INCREASING THE RISK OF SCHIZOPHRENIA AND OTHER MENTAL-HEALTH DISORDERS?](https://www.libd.org/could-the-stress-of-city-life-be-increasing-the-risk-of-schizophrenia-and-other-mental-health-disorders/) - Dr. Weinberger explores stress and the city with Nature’s Allison Abbott. They discuss the idea that scientists are testing, that the stress of modern city life may be a breeding ground for psychosis.
- [DR. SOLOMON SNYDER, DIRECTOR OF LIBD DRUG DISCOVERY, HONORED FOR ACHIEVEMENTS IN NEUROSCIENCE](https://www.libd.org/dr-solomon-snyder-director-of-libd-drug-discovery-honored-for-achievements-in-neuroscience/) - Selected by the National Academy of Services for extraordinary contributions. The Lieber Institute for Brain Development congratulates Dr. Solomon Snyder who has been selected by the National Academy of Sciences to receive its Award for Neuroscience at the 150th annual meeting of the Academy on April 28th. Presented every three years, the award recognizes extraordinary contributions
- [LIBD RESEARCHERS EDIT ARTICLE IN FRONTIERS IN NEUROINFORMATICS](https://www.libd.org/libd-researchers-edit-article-in-frontiers-in-neuroinformatics/) - Drs. Xi Cheng, Anand Mattay, and Daniel Weinberger from the Lieber Institute, along with research colleagues Daniel Marcus, John Van Horn, and Qian Luo, have been invited to edit a special issue of the journal Frontiers in Neuroinformatics. This special issue will be titled ‘Recent advances and the future generation of neuroinformatics infrastructure. Frontiers is an academic publisher
- [NEW GENOME WIDE ASSOCIATION STUDY OF PSYCHIATRIC ILLNESS IS SUBJECT OF LIEBER COMMENT IN THE BOSTON GLOBE AND THE VOICE OF RUSSIA](https://www.libd.org/new-genome-wide-association-study-of-psychiatric-illness-is-subject-of-lieber-comment-in-the-boston-globe-and-the-voice-of-russia/) - You can read the articles on the Boston Globe and Voice of Russia.
- [MEET THE SCIENTIST - A VIRTUAL Q & A](https://www.libd.org/meet-the-scientist-a-virtual-q-a/) - Daniel R. Weinberger, M.D., Director & CEO of the Lieber Institute for Brain Development, participated in the Brain & Behavior Research Foundation’s Meet the Scientist webinar on Tuesday, March 12th and discussed “Research Discoveries in Schizophrenia" with the Foundation’s Acting President and CEO, Jeffrey Borenstein. You can listen to the webinar here.
- [DR. WEINBERGER WEIGHS IN ON CURRENT TRENDS IN REVISING PSYCHIATRIC DIAGNOSIS](https://www.libd.org/dr-weinberger-weighs-in-on-current-trends-in-revising-psychiatric-diagnosis/) - You can read the article here.
- [DR. ERIC KANDEL MEETS WITH INSTITUTE SCIENTISTS AND TRAINEES](https://www.libd.org/dr-eric-kandel-meets-with-institute-scientists-and-trainees/) - On June 3rd, Dr. Kandel visited the Walters Art Gallery in Baltimore as the guest of the Art Seminar Group and the Brain Science Institute to give a lecture in celebration of retiring Walters Director, Gary Vikan. The title of Dr. Kandel’s fascinating talk was about his newly published book, “The Age of Insight: The
- [PATERNAL AGE, DE NOVO MUTATIONS AND SCHIZOPHRENIA](https://www.libd.org/paternal-age-de-novo-mutations-and-schizophrenia/) - A new study by researchers at the Lieber Institute for Brain Development shows that older fathers are not more likely to have children with schizophrenia or other neurodevelopmental behavioral disorders because of new mutations in their genes, as widely reported. The new study which appears in the journal Molecular Psychiatry, contradicts the implications of a
- [FURTHER EXPLORING THE COMPLEXITIES OF THE BRAIN](https://www.libd.org/further-exploring-the-complexities-of-the-brain/) - Brussels, Belgium and Baltimore, Maryland, 30 June, 2013 – Both UCB and the Lieber Institute for Brain Development (LIBD) are committed to innovation and collaboration to help people living with severe brain disorders. As such, they are entering a strategic collaboration for the discovery of new drug candidates for treating patients suffering from cognitive impairment.
- [BRAIN POWER](https://www.libd.org/brain-power/) - http://www.baltimoresun.com/health/maryland-health/bs-bz-lieber-institute-expanding-20130720,0,2353528.story
- [CELEBRATING THE SUMMER AT LIBD!](https://www.libd.org/celebrating-the-summer-at-libd/) - The 2nd annual Lieber Institute for Brain Development crab feast was a great success. Thanks to the folks at Nick’s Fish House for the excellent crabs and terrific water views!
- [LIEBER INSTITUTE EXPANSION PLANS ARE PART OF MARYLAND’S ECONOMIC RECOVERY](https://www.libd.org/lieber-institute-expansion-plans-are-part-of-marylands-economic-recovery/) - The Lieber Institute's expansion is mentioned in a Baltimore Sun. We have exceeded our job growth goals and our exciting plans for expansion! Read More
- [LIEBER INSTITUTE PARTICIPATES IN PARTNERING FOR CURES CONFERENCE IN NEW YORK](https://www.libd.org/lieber-institute-participates-in-partnering-for-cures-conference-in-new-york/) - The Lieber Institute is honored to have been selected to participate as an Innovator in this year’s Partnering for Cures Conference in New York. Partnering for Cures brings together leaders from all sectors in medical research with the express purpose of making collaboration happen - collaborations that must happen if we are to speed up the time it
- [LIEBER INVESTIGATOR NAMED SARAH CRANE VISITING SCHOLAR IN THE HUMANITIES](https://www.libd.org/lieber-investigator-named-sarah-crane-visiting-scholar-in-the-humanities/) - Dr. Caroline Zink, PhD, an Investigator at the Lieber Institute was named the Sarah Crane Visiting Scholar in the Humanities at the Roland Park Country School in Baltimore. Dr. Zink, an alumna of the school, spent the day with the students at this all girls' college preparatory school and gave the keynote lecture for the
- [FROM “THE PINK SHEET” DAILY LIEBER INSTITUTE FILLS GAP IN NEUROPSYCHIATRIC RESEARCH ECOSYSTEM, SEEKS PHARMA PARTNERSHIPS](https://www.libd.org/from-the-pink-sheet-daily-lieber-institute-fills-gap-in-neuropsychiatric-research-ecosystem-seeks-pharma-partnerships/) - http://www.elsevierbi.com/publications/the-pink-sheet-daily/2013/11/7/lieber-institute-fills-gap-in-neuropsychiatric-research-ecosystem-seeks-pharma-partnerships
- [ASTRAZENECA AND LIEBER INSTITUTE FOR BRAIN DEVELOPMENT ANNOUNCE NEUROSCIENCE COLLABORATION](https://www.libd.org/astrazeneca-and-lieber-institute-for-brain-development-announce-neuroscience-collaboration/) - AstraZeneca today announced that it has entered into a two-year research collaboration with the Lieber Institute for Brain Development (LIBD) to use genetics and stem cell biology to discover new therapeutic methods for neuropsychiatric and neurodevelopmental disorders such as autism and schizophrenia. This collaboration brings the expertise at LIBD in human genomics, stem cell biology
- [UNDERGRADUATE RECEIVES HONORS FOR NEUROSCIENCE RESEARCH AT THE LIEBER INSTITUTE](https://www.libd.org/undergraduate-receives-honors-for-neuroscience-research-at-the-lieber-institute/) - Mahima Sukumar, in her second year of undergraduate study at Johns Hopkins has been working with researchers at the Lieber Institute to acquire hands-on laboratory experience that will prepare her for a future career in Neuroscience. Her research project was among those selected to be presented at The Johns Hopkins Neuroscience and Behavioral Biology Poster
- [LIEBER INSTITUTE FOR BRAIN DEVELOPMENT APPOINTS ANDREW MASLAN AS CFO](https://www.libd.org/lieber-institute-for-brain-development-appoints-andrew-maslan-as-cfo/) - The Lieber Institute for Brain Development (LIBD), announced today that Andrew Maslan has been appointed as its Chief Financial Officer, a newly created position. Mr. Maslan will lead all aspects of LIBD’s financial management, and will play a pivotal role in the organization’s business development efforts. With more than 20 years comprehensive financial and general
- [CONGRATULATIONS TO CONNIE AND STEVE LIEBER!](https://www.libd.org/congratulations-to-connie-and-steve-lieber/) - The Lieber Institute congratulates our founders, Connie and Steve Lieber, who received a special Presidential Commendation yesterday at the 167th Annual Meeting of the American Psychiatric Assocociation. This Commendation was given in honor of the Lieber's longstanding and generous support of psychiatric research. Read more.
- [SCIENCE MAGAZINE: "LENGTHY RNAS EARN RESPECT AS CELLULAR PLAYERS"](https://www.libd.org/science-magazine-lengthy-rnas-earn-respect-as-cellular-players/) - Lieber Institute collaborators, Chris Ponting and Wilfried Hearty from the University of Oxford, weigh in on RNA in the June issue of Science Magazine. Read article online.
- [“GENES ARE NOT ABOUT FATE – THEY’RE ABOUT RISK” LIEBER CEO, DANIEL WEINBERGER SAYS IN AN ARTICLE PUBLISHED TODAY IN US NEWS & WORLD REPORT](https://www.libd.org/genes-are-not-about-fate-theyre-about-risk-lieber-ceo-daniel-weinberger-says-in-an-article-published-today-in-us-news-world-report/) - Read article online.
- [LIEBER INSTITUTE AND SHEPPARD PRATT HEALTH SYSTEM BRING SHARED VISION TO NEW JOINT VENTURE RESEARCH ENTITY](https://www.libd.org/lieber-institute-and-sheppard-pratt-health-system-bring-shared-vision-to-new-joint-venture-research-entity/) - With a shared vision of increasing the possibilities for those with mental illness to live full, productive and joyful lives, Sheppard Pratt Health System, Inc. and the Lieber Institute for Brain Development (LIBD) announce a new joint venture to translate scientific advances in genetics and brain research into clinical practice. The new Sheppard Pratt-Lieber Research
- [GLOBAL, COLLABORATIVE APPROACH ADVANCES QUEST FOR BETTER TREATMENTS OF MENTAL ILLNESS](https://www.libd.org/global-collaborative-approach-advances-quest-for-better-treatments-of-mental-illness/) - The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies. DEVELOPING NEW LIBD MEDICATIONS: At LIBD, basic science, clinical research and the development of novel therapeutics are all conducted under one roof. The team filed three
- [LIEBER INSTITUTE FOR BRAIN DEVELOPMENT WINS GRAND PRIZE AT NATIONAL COLLEGIATE RESEARCH CONFERENCE](https://www.libd.org/lieber-institute-for-brain-development-wins-grand-prize-at-national-collegiate-research-conference/) - The National Collegiate Research Conference (NCRC) sponsored by the Harvard College Undergraduate Research Association awarded its 2015 Grand Prize to Mahima Sukumar, an undergraduate student at The Johns Hopkins University, working in the lab of Keri Martinowich, Ph.D., at the Lieber Institute for Brain Development (LIBD). NCRC offers undergraduate students an opportunity to present innovative research
- [TIME MAGAZINE REPORTS ON LIBD PARTNERSHIP WITH VETERANS ADMINISTRATION FOR FIRST-EVER NATIONAL PTSD BRAIN BANK](https://www.libd.org/time-magazine-reports-on-libd-partnership-with-veterans-administration-for-first-ever-national-ptsd-brain-bank/) - The Lieber Institute for Brain Development (LIBD) has already delivered 20 postmortem human brains to the Boston VA Hospital from its vast collection of more than 1,500 extremely well-characterized brains. LIBD collects donated brains from healthy individuals and from people who suffered from a wide range of psychiatric illnesses, including post-traumatic stress disorder (PTSD). Extensive
- [LIEBER INSTITUTE FOR BRAIN DEVELOPMENT SHARES LARGE COLLABORATIVE GRANT TO STUDY ORIGINS OF SCHIZOPHRENIA](https://www.libd.org/lieber-institute-for-brain-development-shares-large-collaborative-grant-to-study-origins-of-schizophrenia/) - BALTIMORE, MD (Apr. 24, 2015)—The Lieber Institute for Brain Development (LIBD) announces the award of a $10.5 million NIH grant to further its efforts to identify the causes of schizophrenia and other neurodevelopmental disorders that will guide development of more precise and effective treatments. From a large and highly competitive applicant pool, the joint LIBD/University
- [PENNINGTON FAMILY FOUNDATION AWARDS $200,000 GRANT TO LIEBER INSTITUTE FOR BRAIN DEVELOPMENT FOR AUTISM RESEARCH](https://www.libd.org/pennington-family-foundation-awards-200000-grant-to-lieber-institute-for-brain-development-for-autism-research/) - BALTIMORE, MD (May 26, 2015)—The Lieber Institute for Brain Development (LIBD) announces the award of a $200,000 grant from the Pennington Family Foundation that will support its efforts to improve the lives of individuals with schizophrenia and related neurodevelopmental disorders. “We are very grateful for this new partnership with the Pennington Family Foundation,” said Daniel R. Weinberger,
- [LIEBER INSTITUTE FOR BRAIN DEVELOPMENT TO MENTOR WALKER AWARDEE ON RESEARCH PROJECT TO STUDY RISK FACTORS OF SUICIDE](https://www.libd.org/lieber-institute-for-brain-development-to-mentor-walker-awardee-on-research-project-to-study-risk-factors-of-suicide/) - The William Walker Awards are granted each year to a small number of medical students at The Johns Hopkins University School of Medicine for summer research projects in psychiatry Sina Shahmatadar, who has just finished his first year of medical school, was selected for a Walker Award to study suicide risk factors with Dr. Thomas
- [HEAR DANIEL R. WEINBERGER, M.D. DESCRIBE THE FIRST FIVE YEARS OF RESEARCH AT THE LIEBER INSTITUTE FOR BRAIN DEVELOPMENT (LIBD)](https://www.libd.org/hear-daniel-r-weinberger-m-d-describe-the-first-five-years-of-research-at-the-lieber-institute-for-brain-development-libd/) - Dr. Weinberger, Founding Director and CEO at LIBD, describes the unique model: to understand how genes and the environment affect the development of the brain, to identify how this is relevant to the risk biology of psychosis, schizophrenia, and related disorders, and to translate these findings into new therapies. Research at LIBD is focused on studying
- [LIEBER INSTITUTE FOR BRAIN DEVELOPMENT APPOINTS KARI STOEVER AS CHIEF EXTERNAL RELATIONS OFFICER](https://www.libd.org/lieber-institute-for-brain-development-appoints-kari-stoever-as-chief-external-relations-officer/) - A global development expert with more than 15 years’ experience in public health startups and advocacy movements, Ms. Stoever will provide strategic guidance to the LIBD leadership and manage all aspects of the organization’s external relations and development efforts. “The creation of the CERO position marks an exciting new phase in the Institute’s growth and
- [LIEBER INSTITUTE AND SEOUL NATIONAL UNIVERSITY ESTABLISH BRAIN TISSUE INITIATIVE](https://www.libd.org/lieber-institute-and-seoul-national-university-establish-brain-tissue-initiative/) - Dan Weinberger, Lieber Institute Director & CEO, Tom Hyde, Chief Operating Officer and Joo Heon Shin, Director of the RNA Sequencing Core at the Institute, traveled to Seoul for the “Commemorative Symposium for the opening of the Seoul National University Hospital (SNUH) Brain Bank” and a collaborative meeting with the Seoul National University, College of
- [IN MEMORY OF CONNIE LIEBER](https://www.libd.org/in-memory-of-connie-lieber/) - For more than 30 years, Connie Lieber led an international movement to bring research about behavioral brain disorders to the forefront of biomedical science. Connie's vision, her determination, and her historic generosity launched thousands of scientific careers. In 2010, she established the Lieber Institute for Brain Development because she was convinced that a new strategy
- [NEUROIMAGING GENETICS: PRINCIPLES AND PRACTICES, EDITED BY DRS. BIGOS AND WEINBERGER](https://www.libd.org/neuroimaging-genetics-principles-and-practices-edited-by-drs-bigos-and-weinberger/) - The volume details cross-disciplinary work in the fields of psychiatry and neurology, with a focus on the use of imaging genetics to further our understanding of molecular mechanisms of risk for neuropsychiatric illness. The advances in imaging genetics and subsequent findings are highlighted throughout the text, providing insight into the underlying relationship of genetics, biological
- [SOURCE OF CELLS USED TO GENERATE NEW TISSUE MAY BE IMPORTANT TO FUTURE OF PERSONALIZED MEDICINE](https://www.libd.org/source-of-cells-used-to-generate-new-tissue-may-be-important-to-future-of-personalized-medicine/) - BALTIMORE—Feb. 25, 2016—New insights suggest that the source of human cells used to generate new tissues and organs may be an important consideration in personalized medicine. The Lieber Institute for Brain Development (LIBD) today released the results of a study highlighting molecular differences in cells that are gaining traction in the field of personalized medicine.
- [UNDER ARMOUR, NFL PLAYERS VISIT THE LIEBER INSTITUTE](https://www.libd.org/under-armour-nfl-players-visit-the-lieber-institute/) - Players from six NFL teams, along with Under Armour representatives, joined the Lieber staff to learn more about the work we are doing to better understand the human brain. The visit was part of the NFLPA Externship with Under Armour, an opportunity provided through the NFL Players Association designed to provide players with experience in
- [DR. KRISTI BIGOS SELECTED AS A FINALIST FOR THE W. LEIGH THOMPSON EXCELLENCE IN RESEARCH AWARD](https://www.libd.org/dr-kristi-bigos-selected-as-a-finalist-for-the-w-leigh-thompson-excellence-in-research-award/) - The winner will be announced at the Johns Hopkins Department of Medicine Research Retreat next Tuesday March 8, 2016. This is an especially great honor for Kristi, who is one of very few non-physicians to be named a finalist for the Clinical Research Faculty Award.
- [DR. KRISTI BIGOS EARNS THE W. LEIGH THOMPSON EXCELLENCE IN RESEARCH AWARD](https://www.libd.org/dr-kristi-bigos-earns-the-w-leigh-thompson-excellence-in-research-award/) - The award was made official on Tuesday, March 8, at the Johns Hopkins Department of Medicine Research Retreat. This is an especially great honor for Kristi, who is one of very few non-physicians to be awarded the Clinical Research Faculty Award. The announcement also came fittingly on International Women’s Day, which we proudly celebrate for
- [CEO & DIRECTOR, DR. WEINBERGER, ISSUES A CALL-TO-ACTION IN THE HILL FOR BRAIN INJURY AWARENESS DAY](https://www.libd.org/ceo-director-dr-weinberger-issues-a-call-to-action-in-the-hill-for-brain-injury-awareness-day/) - Dr. Weinberger calls on the leadership in Washington, DC to build upon the momentum of Brain Injury Awareness Day and declare war on traumatic brain injury and focus on investment in finding better therapies to improve the lives of its victims and their families. Read Full Article
- [LIEBER INSTITUTE JOINS THE CAMPAIGN TO CHANGE DIRECTION](https://www.libd.org/lieber-institute-joins-the-campaign-to-change-direction/) - Nonprofit organizations and private companies are pledging to deliver educational tools and programs to their audiences, and the movement was recently featured by First Lady Michelle Obama in an op-ed published in the Huffington Post. As a leader in medical research of neuropsychiatric disorders, we felt it was important to join the campaign to help
- [WORLD HEALTH DAY 2016](https://www.libd.org/world-health-day-2016/) - Working to understand the brain to help the millions living with mental illness.
- [CONGRESSMAN DUTCH RUPPERSBERGER VISITS LIEBER INSTITUTE](https://www.libd.org/congressman-dutch-ruppersberger-visits-lieber-institute/) - Congressman Dutch Ruppersberger joined the Lieber Institute staff to learn more about the work we are doing to better understand the human brain. The Congressman took a tour of our offices, including a lab demonstration and a stop in the drug discovery lab. It was both an educational and enjoyable visit, and we’d like to
- [LIEBER INSTITUTE’S SNYDER HONORED BY SALK INSTITUTE FOR RESEARCH EXCELLENCE](https://www.libd.org/lieber-institutes-snyder-honored-by-salk-institute-for-research-excellence/) - Regarded internationally for his work in identification of receptors for neurotransmitters and drugs, Dr. Snyder received the prestigious recognition along with Robert Weinberg, an internationally renowned cancer biologist and founding member of the Whitehead Institute. Dr. Snyder received his undergraduate and medical training at Georgetown University before joining the faculty of the Johns Hopkins University
- [LIEBER SCIENTISTS PRESENT RESEARCH AT 11TH ANNUAL AMYGDALA, STRESS & PTSD CONFERENCE](https://www.libd.org/lieber-scientists-present-research-at-11th-annual-amygdala-stress-ptsd-conference/) - Lieber Institute investigators presented a poster at this year's annual Amygdala, Stress and PTSD Conference in Bethesda, MD. The poster, "Genetic risk mechanisms of Post Traumatic Stress Disorder in the human brain," highlights important findings related to genetic risk for developing PTSD. Based on the preliminary results, scientists will now look to implement the approach used
- [EVOLUTIONARY NEW PROTEIN DISCOVERED RELATED TO SCHIZOPHRENIA](https://www.libd.org/evolutionary-new-protein-discovered-related-to-schizophrenia/) - BALTIMORE—May 9, 2016—The Lieber Institute for Brain Development (Lieber Institute), an affiliate of the Johns Hopkins University School of Medicine, and AstraZeneca today released the results of an original study that could lead to the discovery of new treatments for schizophrenia and related neuropsychiatric disorders. Advances in genome-wide association studies have provided scientists with the
- [LIEBER INSTITUTE TRAVELS TO SEOUL, BEIJING AND SINGAPORE](https://www.libd.org/lieber-institute-travels-to-seoul-beijing-and-singapore/) - Dr. Weinberg and Dr. Shin traveled to Asia last month, making several stops along the way to meet with leading experts in the field. In Seoul, they met with representatives at Seoul National University Hospital including Dr. Seo, the CEO of Macrogen and the Director of the Genome Medicine Institute. From Seoul they traveled to
- [LIEBER INSTITUTE DISCOVERY FEATURED IN JUNE ISSUE OF BIOCENTURY INNOVATIONS](https://www.libd.org/lieber-institute-discovery-featured-in-june-issue-of-biocentury-innovations/) - Titled "Red herrings in the gene pool," BioCentury Innovations article featured the recent work of Lieber Institute scientists as part of the Translations in Brief segment. Published last month in the journal Nature Medicine, “A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia locus,” sheds light on why neuropsychiatric disorders are
- [THE LIEBER INSTITUTE FOR BRAIN DEVELOPMENT TO HONOR FOUNDER’S LEGACY THROUGH ESTABLISHMENT OF THE CONSTANCE LIEBER PRIZE FOR INNOVATION IN DEVELOPMENTAL NEUROSCIENCE](https://www.libd.org/the-lieber-institute-for-brain-development-to-honor-founders-legacy-through-establishment-of-the-constance-lieber-prize-for-innovation-in-developmental-neuroscience/) - BALTIMORE—July 21, 2016— The Lieber Institute for Brain Development (LIBD), an affiliate of Johns Hopkins University School of Medicine, announced today a new prize in the field of developmental neuroscience in memory of Constance Lieber, one of the Institute’s founders. The Constance Lieber Prize for Innovation in Developmental Neuroscience will be awarded in June of
- [LIEBER INSTITUTE FOR BRAIN DEVELOPMENT APPOINTS DR. STEVE SHARFSTEIN TO BOARD](https://www.libd.org/lieber-institute-for-brain-development-appoints-dr-steve-sharfstein-to-board/) - BALTIMORE—November 29, 2016—The Lieber Institute for Brain Development (LIBD), an affiliate of the Johns Hopkins University School of Medicine, announced today that Dr. Steven S. Sharfstein has joined the Institute’s Board of Directors. A pioneer in the mental health community with 25 years’ as Sheppard Pratt Health System (SPH) president and CEO, Dr. Sharfstein will
- [LIEBER INSTITUTE STAFF EARN AWARDS AT 4TH ANNUAL GENETICS RESEARCH DAY](https://www.libd.org/lieber-institute-staff-earn-awards-at-4th-annual-genetics-research-day/) - In the Postdoctoral fellow category Carrie Wright earned 1st place for her poster, “Evaluation of isomiRNA expression in schizophrenia using small RNA sequencing of postmortem dorsolateral prefrontal cortex brain tissue.” Nina Rajpurohit’s poster, “Investigating Expression of Epistatic Interaction Networks in Bipolar Disorder in Human Dorsolateral Prefrontal Cortex,” came in 2ndplace in the Masters Students category.

## Pages

- [Home Page](https://www.libd.org/) - LIEBER INSTITUTEFOR BRAIN DEVELOPMENT Unlocking the Mysteries of the Brain. Our Ambitious Goal Impact through research Schizophrenia Health Disparities Maternal & Child Health Mood disorders Autism Addiction Suicide Aging disorders PTSD Schizophrenia Watching a loved one go through their first psychotic episode can be a life-altering, terrifying experience. Schizophrenia robs young people of their chance
- [end mental illness](https://www.libd.org/endmentalillness/) - We Can End Mental Illness What if we could stop mental illness before it takes hold? This isn’t arrogance — it’s focus, fueled by the precision of science. Join us in turning loss into lasting change. Support Today Ways to Get Involved We’re building a future where every mind has a chance to thrive but
- [Careers](https://www.libd.org/careers/) - View our career opportunities with Lieber Institute for Brain Development including investigators, medical research jobs, scientists, & lab techs
- [Brain and Placenta Genomics LAB](https://www.libd.org/brainandplacentagenomicslab/) - Understanding how genes and the environment interact in early life at the placenta to influence trajectories of risk for neurodevelopmental disorders.
- [Nolan's story](https://www.libd.org/nolans-story/) - Nolan never backed down from anyone. Neither do we For millions of people living with mental illness and everyone who loves them, that world is not a dream. It is the work being done right now. Honor a life What Your Donation Does DID YOU KNOW Americans 1 iN 5 Americans are living with a
- [Imagine A world](https://www.libd.org/imagine-a-world/) - Imagine a world where the answer exists For millions of people living with mental illness and everyone who loves them, that world is not a dream. It is the work being done right now. Give Today What Your Donation Does DID YOU KNOW Americans 1 iN 5 Americans are living with a mental illness right
- [LinkedIn Newsletter Signup](https://www.libd.org/newsletter/) - Science this good shouldn't stay in a lab Tailored Information Personalized for You
- [Data Science/Computational Biology](https://www.libd.org/data-sciencecomputational-biology/) - Combining data science & computational biology, LIBD runs clinical trials for schizophrenia, PTSD, head trauma, TBI, & Parkinson's treatment advancement.
- [Give Monthly](https://www.libd.org/give-monthly/) - Give Monthly Prevent Mental Illness, One Month at a Time WHAT IS THE BRAIN TRUST When you give monthly, you become part of The Brain Trust — a community of courageous and committed supporters helping scientists uncover the root causes of mental illness. Each trustee (that's what we call our supporters)... Believes in the power
- [Summer 26 Race](https://www.libd.org/summer-26-race/) - Miles for Minds Summer Run Series Join runners across the country dedicating their miles to support brain research and prevent mental illness.Whether you’re training for a race or running your usual route, you can turn your miles into impact. Sign Up Get Excited for the movement WHY YOUR MILES MATTER 1 FUEL BREAKTHROUGH RESEARCH At
- [Libd lens](https://www.libd.org/libd-lens/) - Lieber LENS The goal of research at LIBD is to identify new strategies to change the lives of individuals affected by schizophrenia and related developmental disorders. Immunofluorescence Staining of the Adult Hippocampus for Markers of the Neurovascular Unit Madeline Abramson Lab: Page Lab (Imaging Development Group)/Translational Neuroscience Staining of a neurotypical control donor with MAP2
- [New Drug Discovery Pipeline](https://www.libd.org/new-drug-discovery-pipeline/) - Drug Discovery Pipeline The goal of research at LIBD is to identify new strategies to change the lives of individuals affected by schizophrenia and related developmental disorders. From Genes to Drugs Rather than focusing on disease specific molecules, our drug development program has identified targets with much broader clinical application, focusing on chemicals involved in
- [PTSD](https://www.libd.org/ptsd/) - PTSD Trauma That Lasts a Lifetime Post-traumatic stress disorder (PTSD) affects people who experience a traumatic event beyond ordinary day-to-day stressors. It’s normal to feel anxious and frightened in the moment, but people with PTSD carry that fear—and their body’s reactions to it—long after their trauma. PTSD can affect people who have experienced violence,
- [Drug Discovery & Development](https://www.libd.org/drug-discovery-development/) - Our drug discovery program helps in the development of new drugs to combat schizophrenia, PTSD, bipolar & other brain disorders using clinical research/trials.
- [Autism](https://www.libd.org/autism/) - Learn more about autism, autism causes, brain development & cognitive functioning & how LIBD is using clinical research & medical trials for mental illness.
- [Board of Directors](https://www.libd.org/board-of-directors/) - Our Board of Directors is responsible for strategic planning, oversight, and executive management for mental illness research & clinical trials.
- [Scientific Advisory Board](https://www.libd.org/scientific-advisory-board/) - Scientists on our independent Scientific Advisory Board (SAB) work on finding cures for mental illness, including schizophrenia, PTSD, bipolar, & Alzheimer's.
- [Summer Internship](https://www.libd.org/summer-2020-program/) - Summer internship
- [LIBD 10th Anniversary Report](https://www.libd.org/libd-10th-anniversary-report/) - LIBD 10th anniversary Report The 10th Anniversary Report – 2021 View PDF via the cover image right. Questions? Contact: Oluwaseyi Abujade
- [Manage Profile](https://www.libd.org/manage-profile/) - Hi [fka_contact_name] your email is [fka_contact_email]. [fka_contact_profile_form]
- [Internships](https://www.libd.org/internships/) - Summer & Academic Year Internships are designed to deliver a rich & unique educational experience to students. Must be 18 years of age or older.
- [Staff](https://www.libd.org/staff/) - Meet our team of world-class scientists & who study mental health & brain disorders, including Autism, PTSD, Alzheimer's, TBI, & schizophrenia
- [Conflict of Interest Policy](https://www.libd.org/conflict-of-interest-policy/) - Conflict of Interest Policy
- [Donor Families](https://www.libd.org/families/) - OUR FAMILIES Donor Families Make the Lieber Institute’s Science Possible Donor Families Power Our Groundbreaking Science The Lieber Institute for Brain Development’s greatest resource is its collection of donated brains, the largest collection of brains in the world that’s devoted to enhancing science’s understanding of psychiatric disorders. Each brain is donated by a bereaved family
- [Ways to Give](https://www.libd.org/ways-to-give/) - One Time Gift Make an immediate impact, your donation fuels breakthrough discoveries in mental health. Give Monthly Power progress every day. Your steady support drives lasting change. Honor Someone Give in tribute to someone you love and help protect future minds in their name. Phone or Mail Prefer a personal touch? We’ll help you make
- [Impact](https://www.libd.org/impact/) - Impact Exploring the brain to treat, cure and prevent mental health conditions and aging-brain disorders On the path toward treatments, cures and prevention. The silence surrounding mental health conditions and aging-brain disorders is slowly breaking, yet the need for understanding and effective solutions has never been greater. Millions of lives are touched by these conditions,
- [Benefits](https://www.libd.org/careers/benefits/) - Benefits
- [One Last Thing](https://www.libd.org/one-last-thing/) - One last thing... would you consider a gift to the Lieber Institute for Brain Development, today. Every gift fuels the research to preventing mental illness.
- [Press Resources](https://www.libd.org/press-resources/)
- [Collaborators & Partners](https://www.libd.org/collaboration-partners/) - Our worldwide collaborators & partners continue to aid us in treating brain disorders/diseases, including PTSD, bipolar, Alzheimer's, schizophrenia & more.
- [Mission](https://www.libd.org/mission/) - Our mission: Understanding mechanisms of brain/mental disorders through developmental research for PTSD, schizophrenia, bipolar, Parkinson's & Alzheimer's.
- [Donor Advised Fund](https://www.libd.org/donor-advised-fund/) - Donor Advised fund (DAF) A Personal Tax-Advantaged Charitable Giving Account How to give from your DAF to the Lieber Institute for Brain Development Recommend a contribution with DAFwidget DAFwidget makes it simple and convenient to find over 900 funds. Get your process started by clicking below. Please request your name be added to the memo
- [Privacy Policy](https://www.libd.org/privacy-policy/) - Privacy Policy
- [Survey](https://www.libd.org/survey/) - And the Survey says... Your response helps guide us. We envision a world free from mental illness. Millions of people are impacted by a severe mental illness. Every year one out of five people will experience a major mental health issue which can ripple to impact financial, relationship and medical wellbeing. Mental illness is not #
- [Signup](https://www.libd.org/signup/) - Subscribe to stay informed Tailored Information Personalized for You We envision a world free from mental illness. Millions of people are impacted by a severe mental illness. Every year one out of five people will experience a major mental health issue which can ripple to impact financial, relationship and medical wellbeing. Mental illness is not
- [Lieber Notes](https://www.libd.org/lieber-notes/) - Stay Updated with News of Our Latest Breakthroughs Lieber Notes is the Institute’s newsletter for our valued donors and stakeholders. Subscribing is the best way to stay updated on the Institute’s groundbreaking science and research. Each issue features a story about a brain donor family, a description of one our latest research accomplishments, and recent highlights
- [Donate Stock](https://www.libd.org/donate-stock/) - Donate Stock Maximize your impact, Minimize your taxes Did you know stock gifting is the most tax-friendly ways to support our mission? When you donate stock, you may avoid the tax on the gain while deducting 100% of the value of the contribution. And when you donate stock, we get to keep the proceeds that would
- [Addiction](https://www.libd.org/addiction/) - Addiction New Hope for Families Addiction is a national public health crisis that can have devastating consequences for patients and their families. The COVID-19 pandemic has only made the situation more desperate. In 2020, the U.S. set a record for the most overdose deaths in a year—more than 93,000 people died of an overdose that
- [Webinar](https://www.libd.org/webinar/) - What if artificial intelligence could help us unlock the mysteries of the brain—and speed up the search for new treatments for mental illness and age-related brain diseases? Join us for a fascinating, accessible conversation with AI research experts Dr. Shizhong Han and Dr. Michael Nagle of the Lieber Institute for Brain Development. These pioneering scientists are using cutting-edge AI
- [Brain Repository](https://www.libd.org/brain-repository/) - LIBD has the largest collection of postmortem human brains. These donated brains help schizophrenia, bipolar, PTSD & other mental disorder research/trials.
- [Aging](https://www.libd.org/aging/) - Aging The Challenges of Growing Older People are living longer, and that means more time to enjoy the pleasures of one’s life—spending time with family, practicing beloved hobbies, studying topics of interest. But at the same time, longer lives mean more time for the health problems that come with aging. Babies born in the U.S.
- [Add my name](https://www.libd.org/add-my-name/) - Getting to know you Tailored Information Personalized for You We envision a world free from mental illness. Millions of people are impacted by a severe mental illness. Every year one out of five people will experience a major mental health issue which can ripple to impact financial, relationship and medical wellbeing. Mental illness is not
- [Suicide](https://www.libd.org/suicide/) - Suicide Can we prevent suicide? Suicide is the 10th leading cause of death in the U.S. It is unique among psychiatric disorders in that a short, intense moment of active suicidal crisis may end a person’s life forever—the most severe of consequences. However, there is no treatment that specifically targets suicide. Instead, therapies focus on
- [Mood Disorders](https://www.libd.org/mood-disorders/) - Mood Disorders Genes, The Environment And Mood Mood disorders such as depression, anxiety, and bipolar disorder are relatively common—affecting one in five people—and can be debilitating. Depression involves feelings of sadness, low energy, and often sleep disruptions. Bipolar disorder involves depression with periods of mania, a condition that consists of an overabundance of energy and
- [Maternal & Child Health](https://www.libd.org/maternal-child-health/) - Maternal & Child Health The Importance of Early Childhood Development Early childhood is a crucial time that sets up children for a lifetime of adaptation to the complexities of human life. During the first five years of life, stress is a risk factor for depression, anxiety disorders, drug abuse, and many other medical conditions. But
- [Health Disparities](https://www.libd.org/health-disparities/) - Health Disparities Seeking a Cure for Disparities in Science and Medicine Systemic racism in the U.S. has shaped the country’s health care and biomedical research systems. We see evidence in the disparities in health outcomes across racial and ethnic groups, an academic research enterprise that doesn’t capitalize on the country’s diverse pool of talent to
- [Schizophrenia](https://www.libd.org/schizophrenia/) - Accompany LIBD as we use medical research & clinical trials to advance schizophrenia awareness & treat brain illnesses such as bipolar, Alzheimer's & PTSD.
- [Academic Year Internship](https://www.libd.org/academic-year-2019-2020-program/) - Academic year internship
- [Town Hall](https://www.libd.org/town-hall/) - Please join us for the first of a series of events only for you, our brain donor families. On Feb. 18 at 12pm EST, founding Director and CEO of the Institute Dr. Daniel Weinberger will join Chief Medical Officer Dr. Tom Hyde for a free, live, online town hall exclusive to brain donor families.
- [Functional Genomics](https://www.libd.org/functional-genomics/) - Using functional genomics, we develop models showing how genes influence schizophrenia, PTSD, bipolar, Alzeihemer's & other developmental brain disorders.
- [Publications](https://www.libd.org/publications/) - Visit Lieber Institute for Brain Development's publications for medical advances in schizophrenia, PTSD, bipolar & other mental illness research & trials.
- [Let's Keep In Touch](https://www.libd.org/lets-keep-in-touch/) - Hi [bwfan_subscriber_name] Help us to improve your experience with us through better communication. Please adjust your preferences for email [bwfan_subscriber_recipient]. [bwfan_unsubscribe_button label="Update my preference"].
- [Shop](https://www.libd.org/shop/)
- [Drug Discovery Pipeline](https://www.libd.org/drug-discovery/) - Our drug discovery research provides new advances in schizophrenia & other related developmental brain disorders-PTSD, bipolar, Alzheimer's, & Parkinson's.
- [neuroDEVELOPMENTS](https://www.libd.org/neurodevelopments/) - NEURODEVELOPMENTS Neuroscience Research to Clinical Relevance Through the genomic sands of time For this issue of neuroDEVELOPMENTS, we celebrate the Nobel Prize awarded to Svante Pääbo in December 2022 for his work deciphering the DNA sequence of ancient hominids. To mark the occasion, we highlight two papers that delve into how evolutionarily recent genome variation in primates has
- [2019 LIBD Annual Report](https://www.libd.org/2019-libd-annual-report/) - 2019 LIBD Annual Report The 2019 Annual Report View PDF via the cover image right. Support the Mission The Lieber Institute for Brain Development is an independent, not-for-profit 501(c)(3) medical research organization dedicated to improving the lives of individuals suffering from schizophrenia and related brain disorders. Make a donation in support of our mission: ORChecks
- [Molecular Neuropathology](https://www.libd.org/molecular-neuropathology/) - Molecular neuropathology studies brain tissue for the advancement of brain disorders including schizophrenia, Alzheimers's, Parkinson's, PTSD, & bipolar.
- [Molecular Psychiatry/Imaging Genetics](https://www.libd.org/molecular-psychiatry-image-genetics/) - Using gene influence, LIBD's molecular psychiatry is able to understand how the human genome affects brain disorders including schizophrenia, bipolar & PTSD.
- [Developmental Biology](https://www.libd.org/development-biology/) - The goal of our developmental Biology program is to normalize brain functions in patients with brain disorders through clinical research.
- [Clinical Pharmacology](https://www.libd.org/clinical-pharmacology/) - Clinical pharmacology advances medical research/trials for brain disorders, including schizophrenia, PTSD, bipolar, Alzheimer's & Parkinson's.
- [Important Breakthroughs](https://www.libd.org/important-breakthroughs/) - Important Breakthroughs Scientific achievements and discoveries from the Institute New study finds placenta health affects risk of schizophrenia A team of researchers led by Drs. Gianluca Ursini and Daniel R. Weinberger found the placenta plays a key role for risk for schizophrenia and other neurodevelopmental disorders. In contrast to prior studies which focused on how
- [Translational Clinical Programs](https://www.libd.org/translational-clinical-programs/) - Our programs include clinical research & medical brain trials to advance brain development & mental health studies for brain disorders, schizophrenia & PTSD
- [BrainSEQTM Consortium](https://www.libd.org/brainseq-consortium/) - Learn more about BrainSEQ, a collaboration providing advanced medical research & clinical studies data for mental health & brain disorders.
- [Our Approach](https://www.libd.org/our-approach/) - Our Approach A unique, multidisciplinary translational research institute Changing the research landscape In the increasingly complex world of big science, the Lieber Institute for Brain Development was created to embody a unique flavor and culture, a one-of-a kind oasis. Our founding credo was to bring scientists with diverse experience and perspectives together in a common
- [Contact Us](https://www.libd.org/contact-us/) - Contact us to stay updated on news, discoveries, & upcoming events for mental health disorders at Lieber Institute for Brain Development. Call 410-955-1000
- [Constance Lieber Prize](https://www.libd.org/constance-lieber-prize-2/) - Constance Lieber Prize for Innovation in Developmental Neuroscience It is a great honor to recognize Connie Lieber’s leadership in the area of mental health research, her prescient insights about the central role of brain development, and to inspire the next generation of scientists in the developmental neurosciences with this biennial prize in her name. Constance
- [Champions Council](https://www.libd.org/champions-council/) - The Lieber Institute Champions Council includes prominent influencers with a personal interest in the Institute's mission.
- [Human Cell Lines](https://www.libd.org/human-cells-lines/) - Over 1,000 human cell lines help with brain research for schizophrenia, bipolar, PTSD, Alzheimer's, Parkinson's & other mental illnesses & brain disorders.
- [The Rose Window](https://www.libd.org/the-rose-window/) - Renowned neuroscientist Dr. Daniel Weinberger discusses the science of mental health and brain illnesses such as schizophrenia, bipolar disorder and depression.
- [Contribute](https://www.libd.org/contribute/) - Contact us to contribute to our brain disorder research & medical clinical trials for mental illness such as PTSD, bipolar, Alzheimer's, & Parkinson's.
- [Subscribe](https://www.libd.org/subscribe/) - Subscribe to LIBD Newsletters
- [ConstanceLieberPrize](https://www.libd.org/constance-lieber-prize/) - Learn more about the Constance Lieber Prize for mental health research in the fields of schizophrenia, PTSD, Alzheimer's, Parkinson's & bipolar mental disorders.
- [Graduate Rotations](https://www.libd.org/graduate-rotations/) - Graduate Student Rotations We are looking for talented and ambitious students to join us in this important effort.
- [News & Events](https://www.libd.org/news-events/) - Learn more about our mental disorder & brain illness news & events for schizophrenia, bipolar, PTSD, Alzheimer's & Parkinson's research & clinical studies.
- [Media & Press Resources](https://www.libd.org/media-and-press-resources/) - View Lieber Institute for Brain Development's media & press resources for bipolar, schizophrenia, PTSD, Parkinson's & other mental health information.
- [Downloads & Links](https://www.libd.org/downloads-links/) - Downloads & Links for mental disorders including PTSD, bipolar, Alzheimer's, Parkinson's & schizophrenia from Lieber Institute for Brain Development.
- [Connect](https://www.libd.org/connect/) - Stay connected with Lieber Institute for Brain Development on Facebook & Twitter for updates regarding mental health & brain disorder awareness.
- [Become an Advocate](https://www.libd.org/become-an-advocate/) - Become an advocate for LIBD as we work towards overcoming and curing mental health & brain illness, including PTSD, Alzheimer's, schizophrenia, & bipolar.
- [Events](https://www.libd.org/events/)
- [2016 Publications](https://www.libd.org/publications/2016-publications/)
- [2011 Publications](https://www.libd.org/publications/2011-publications/)
- [2012 Publications](https://www.libd.org/publications/2012-publications/)
- [2013 Publications](https://www.libd.org/publications/2013-publications/)
- [2014 Publications](https://www.libd.org/publications/2014-publications/)
- [2015 Publications](https://www.libd.org/publications/2015-publications/)
- [Cortical Development](https://www.libd.org/development-biology/cortical-development/) - Cortical Development
- [Environmental Genomics](https://www.libd.org/functional-genomics/environmental-genomics/) - Environmental Genomics
- [Cognitive Neuroscience](https://www.libd.org/molecular-psychiatry-image-genetics/cognitive-neuroscience/) - Cognitive Neuroscience Functional MRI, imaging genetics, and machine learning
- [Research Inquiries](https://www.libd.org/research-inquiries/) - Contact us today for research inquiries regarding our investigations in brain development and mental health disorders such as bipolar & PTSD.
- [Computational Neuropsychiatry](https://www.libd.org/molecular-psychiatry-image-genetics/computational-neuropsychiatry/) - Computational Neuropsychiatry
- [Assay Development](https://www.libd.org/drug-discovery-development/assay-development/) - Assay Development
- [Medicinal Chemistry](https://www.libd.org/drug-discovery-development/medicinal-chemistry-2/) - Medicinal Chemistry
- [In vivo Pharmacology](https://www.libd.org/drug-discovery-development/in-vivo-pharmacology/) - In vivo Pharmacology
- [Neural Plasticity](https://www.libd.org/development-biology/neural-plasticity/) - Neural Plasticity
- [Stem Cell Biology](https://www.libd.org/development-biology/stem-cell-biology/) - Stem Cell Biology
- [Past Events](https://www.libd.org/past-events/)
- [Drug Discovery & Development2](https://www.libd.org/drug-discovery-development-2/)
- [content-style](https://www.libd.org/content-style/) - Headline 1 Translating genetic insights into next geration treatments.
- [Resources](https://www.libd.org/resources/)
- [More](https://www.libd.org/more/)

## ElementsKit items

- [dynamic-content-megamenu-menuitem276](https://www.libd.org/elementskit-content/dynamic-content-megamenu-menuitem276/) - ABOUT US Mission Scientific Advisory Board Staff Directory Careers Collaborators & Partners Contact Us Board of Directors WHAT WE DO Ancestry Research Schizophrenia PTSD Mood Disorders Suicide Addiction Autism Aging Maternal & Child Health Brain Donor Program Brain Repository Our Drug Discovery Pipeline OUR COMMUNITY OF SCIENCE Important Breakthroughs Functional Genomics Clinical Pharmacology Data Science/Computational

## Templates

- [Mega Menu](https://www.libd.org/?elementskit_template=mega-menu) - ABOUT US Mission Scientific Advisory Board Staff Directory Careers Collaborators & Partners Contact Us Board of Directors WHAT WE DO Ancestry Research Schizophrenia PTSD Mood Disorders Suicide Addiction Autism Aging Maternal & Child Health Brain Donor Program Brain Repository Our Drug Discovery Pipeline OUR COMMUNITY OF SCIENCE Important Breakthroughs Functional Genomics Clinical Pharmacology Data Science/Computational

## Entries

- [](https://www.libd.org/vfb_entry/13646/)
- [](https://www.libd.org/vfb_entry/13640/)
- [](https://www.libd.org/vfb_entry/13637/)
- [](https://www.libd.org/vfb_entry/13636/)
- [](https://www.libd.org/vfb_entry/13635/)
- [](https://www.libd.org/vfb_entry/13634/)
- [](https://www.libd.org/vfb_entry/13633/)
- [](https://www.libd.org/vfb_entry/13632/)
- [](https://www.libd.org/vfb_entry/13621/)
- [](https://www.libd.org/vfb_entry/13618/)
- [](https://www.libd.org/vfb_entry/13617/)
- [](https://www.libd.org/vfb_entry/13616/)
- [](https://www.libd.org/vfb_entry/13611/)
- [](https://www.libd.org/vfb_entry/13607/)
- [](https://www.libd.org/vfb_entry/13554/)
- [](https://www.libd.org/vfb_entry/13553/)
- [](https://www.libd.org/vfb_entry/13552/)
- [](https://www.libd.org/vfb_entry/13551/)
- [](https://www.libd.org/vfb_entry/13550/)
- [](https://www.libd.org/vfb_entry/13549/)
- [](https://www.libd.org/vfb_entry/13481/)
- [](https://www.libd.org/vfb_entry/13472/)
- [](https://www.libd.org/vfb_entry/13471/)
- [](https://www.libd.org/vfb_entry/13470/)
- [](https://www.libd.org/vfb_entry/13469/)
- [](https://www.libd.org/vfb_entry/13462/)
- [](https://www.libd.org/vfb_entry/13461/)
- [](https://www.libd.org/vfb_entry/13460/)
- [](https://www.libd.org/vfb_entry/13457/)
- [](https://www.libd.org/vfb_entry/13455/)
- [](https://www.libd.org/vfb_entry/13454/)
- [](https://www.libd.org/vfb_entry/13453/)
- [](https://www.libd.org/vfb_entry/13452/)
- [](https://www.libd.org/vfb_entry/13451/)
- [](https://www.libd.org/vfb_entry/13429/)
- [](https://www.libd.org/vfb_entry/13428/)
- [](https://www.libd.org/vfb_entry/13427/)
- [](https://www.libd.org/vfb_entry/13426/)
- [](https://www.libd.org/vfb_entry/13425/)
- [](https://www.libd.org/vfb_entry/13424/)
- [](https://www.libd.org/vfb_entry/13423/)
- [](https://www.libd.org/vfb_entry/13422/)
- [](https://www.libd.org/vfb_entry/13403/)
- [](https://www.libd.org/vfb_entry/13398/)
- [](https://www.libd.org/vfb_entry/13397/)
- [](https://www.libd.org/vfb_entry/13396/)
- [](https://www.libd.org/vfb_entry/13384/)
- [](https://www.libd.org/vfb_entry/13383/)
- [](https://www.libd.org/vfb_entry/13379/)
- [](https://www.libd.org/vfb_entry/13378/)
- [](https://www.libd.org/vfb_entry/13334/)
- [](https://www.libd.org/vfb_entry/13330/)
- [](https://www.libd.org/vfb_entry/13329/)
- [](https://www.libd.org/vfb_entry/13328/)
- [](https://www.libd.org/vfb_entry/13327/)
- [](https://www.libd.org/vfb_entry/13326/)
- [](https://www.libd.org/vfb_entry/13325/)
- [](https://www.libd.org/vfb_entry/13324/)
- [](https://www.libd.org/vfb_entry/13323/)
- [](https://www.libd.org/vfb_entry/13322/)
- [](https://www.libd.org/vfb_entry/13317/)
- [](https://www.libd.org/vfb_entry/13316/)
- [](https://www.libd.org/vfb_entry/13315/)
- [](https://www.libd.org/vfb_entry/13314/)
- [](https://www.libd.org/vfb_entry/13313/)
- [](https://www.libd.org/vfb_entry/13312/)
- [](https://www.libd.org/vfb_entry/13311/)
- [](https://www.libd.org/vfb_entry/13305/)
- [](https://www.libd.org/vfb_entry/13304/)
- [](https://www.libd.org/vfb_entry/13303/)
- [](https://www.libd.org/vfb_entry/13302/)
- [](https://www.libd.org/vfb_entry/13301/)
- [](https://www.libd.org/vfb_entry/13300/)
- [](https://www.libd.org/vfb_entry/13220/)
- [](https://www.libd.org/vfb_entry/13219/)
- [](https://www.libd.org/vfb_entry/13217/)
- [](https://www.libd.org/vfb_entry/13213/)
- [](https://www.libd.org/vfb_entry/13212/)
- [](https://www.libd.org/vfb_entry/13211/)
- [](https://www.libd.org/vfb_entry/13210/)
- [](https://www.libd.org/vfb_entry/13209/)
- [](https://www.libd.org/vfb_entry/13188/)
- [](https://www.libd.org/vfb_entry/13187/)
- [](https://www.libd.org/vfb_entry/13186/)
- [](https://www.libd.org/vfb_entry/13185/)
- [](https://www.libd.org/vfb_entry/13184/)
- [](https://www.libd.org/vfb_entry/13179/)
- [](https://www.libd.org/vfb_entry/13178/)
- [](https://www.libd.org/vfb_entry/13159/)
- [](https://www.libd.org/vfb_entry/13148/)
- [](https://www.libd.org/vfb_entry/13107/)
- [](https://www.libd.org/vfb_entry/13106/)
- [](https://www.libd.org/vfb_entry/13105/)
- [](https://www.libd.org/vfb_entry/13058/)
- [](https://www.libd.org/vfb_entry/13057/)
- [](https://www.libd.org/vfb_entry/12971/)
- [](https://www.libd.org/vfb_entry/12962/)
- [](https://www.libd.org/vfb_entry/12961/)
- [](https://www.libd.org/vfb_entry/12960/)
- [](https://www.libd.org/vfb_entry/12959/)
- [](https://www.libd.org/vfb_entry/12883/)
- [](https://www.libd.org/vfb_entry/12881/)
- [](https://www.libd.org/vfb_entry/12870/)
- [](https://www.libd.org/vfb_entry/12869/)
- [](https://www.libd.org/vfb_entry/12868/)
- [](https://www.libd.org/vfb_entry/12867/)
- [](https://www.libd.org/vfb_entry/12866/)
- [](https://www.libd.org/vfb_entry/12865/)
- [](https://www.libd.org/vfb_entry/12864/)
- [](https://www.libd.org/vfb_entry/12856/)
- [](https://www.libd.org/vfb_entry/12792/)
- [](https://www.libd.org/vfb_entry/12791/)
- [](https://www.libd.org/vfb_entry/12790/)
- [](https://www.libd.org/vfb_entry/12778/)
- [](https://www.libd.org/vfb_entry/12777/)
- [](https://www.libd.org/vfb_entry/12776/)
- [](https://www.libd.org/vfb_entry/12775/)
- [](https://www.libd.org/vfb_entry/12774/)
- [](https://www.libd.org/vfb_entry/12773/)
- [](https://www.libd.org/vfb_entry/12772/)
- [](https://www.libd.org/vfb_entry/12771/)
- [](https://www.libd.org/vfb_entry/12770/)
- [](https://www.libd.org/vfb_entry/12769/)
- [](https://www.libd.org/vfb_entry/12764/)
- [](https://www.libd.org/vfb_entry/12757/)
- [](https://www.libd.org/vfb_entry/12756/)
- [](https://www.libd.org/vfb_entry/12755/)
- [](https://www.libd.org/vfb_entry/12754/)
- [](https://www.libd.org/vfb_entry/12753/)
- [](https://www.libd.org/vfb_entry/12728/)
- [](https://www.libd.org/vfb_entry/12723/)
- [](https://www.libd.org/vfb_entry/12700/)
- [](https://www.libd.org/vfb_entry/12693/)
- [](https://www.libd.org/vfb_entry/12692/)
- [](https://www.libd.org/vfb_entry/12691/)
- [](https://www.libd.org/vfb_entry/12690/)
- [](https://www.libd.org/vfb_entry/12689/)
- [](https://www.libd.org/vfb_entry/12684/)
- [](https://www.libd.org/vfb_entry/12682/)
- [](https://www.libd.org/vfb_entry/12681/)
- [](https://www.libd.org/vfb_entry/12680/)
- [](https://www.libd.org/vfb_entry/12679/)
- [](https://www.libd.org/vfb_entry/12678/)
- [](https://www.libd.org/vfb_entry/12677/)
- [](https://www.libd.org/vfb_entry/12676/)
- [](https://www.libd.org/vfb_entry/12660/)
- [](https://www.libd.org/vfb_entry/12648/)
- [](https://www.libd.org/vfb_entry/12646/)
- [](https://www.libd.org/vfb_entry/12619/)
- [](https://www.libd.org/vfb_entry/12616/)
- [](https://www.libd.org/vfb_entry/12608/)
- [](https://www.libd.org/vfb_entry/12607/)
- [](https://www.libd.org/vfb_entry/12606/)
- [](https://www.libd.org/vfb_entry/12602/)
- [](https://www.libd.org/vfb_entry/12597/)
- [](https://www.libd.org/vfb_entry/12596/)
- [](https://www.libd.org/vfb_entry/12595/)
- [](https://www.libd.org/vfb_entry/12563/)
- [](https://www.libd.org/vfb_entry/12562/)
- [](https://www.libd.org/vfb_entry/12561/)
- [](https://www.libd.org/vfb_entry/12560/)
- [](https://www.libd.org/vfb_entry/12559/)
- [](https://www.libd.org/vfb_entry/12558/)
- [](https://www.libd.org/vfb_entry/12557/)
- [](https://www.libd.org/vfb_entry/12556/)
- [](https://www.libd.org/vfb_entry/12555/)
- [](https://www.libd.org/vfb_entry/12554/)
- [](https://www.libd.org/vfb_entry/12553/)
- [](https://www.libd.org/vfb_entry/12551/)
- [](https://www.libd.org/vfb_entry/12550/)
- [](https://www.libd.org/vfb_entry/12549/)
- [](https://www.libd.org/vfb_entry/12548/)
- [](https://www.libd.org/vfb_entry/12547/)
- [](https://www.libd.org/vfb_entry/12546/)
- [](https://www.libd.org/vfb_entry/12536/)
- [](https://www.libd.org/vfb_entry/12530/)
- [](https://www.libd.org/vfb_entry/12523/)
- [](https://www.libd.org/vfb_entry/12522/)
- [](https://www.libd.org/vfb_entry/12521/)
- [](https://www.libd.org/vfb_entry/12520/)
- [](https://www.libd.org/vfb_entry/12519/)
- [](https://www.libd.org/vfb_entry/12518/)
- [](https://www.libd.org/vfb_entry/12517/)
- [](https://www.libd.org/vfb_entry/12516/)
- [](https://www.libd.org/vfb_entry/12515/)
- [](https://www.libd.org/vfb_entry/12442/)
- [](https://www.libd.org/vfb_entry/12441/)
- [](https://www.libd.org/vfb_entry/12433/)
- [](https://www.libd.org/vfb_entry/12432/)
- [](https://www.libd.org/vfb_entry/12431/)
- [](https://www.libd.org/vfb_entry/12430/)
- [](https://www.libd.org/vfb_entry/12429/)
- [](https://www.libd.org/vfb_entry/12425/)
- [](https://www.libd.org/vfb_entry/12316/)
- [](https://www.libd.org/vfb_entry/12315/)
- [](https://www.libd.org/vfb_entry/12314/)
- [](https://www.libd.org/vfb_entry/12313/)
- [](https://www.libd.org/vfb_entry/12312/)
- [](https://www.libd.org/vfb_entry/12311/)
- [](https://www.libd.org/vfb_entry/12310/)
- [](https://www.libd.org/vfb_entry/12309/)
- [](https://www.libd.org/vfb_entry/12308/)
- [](https://www.libd.org/vfb_entry/12307/)
- [](https://www.libd.org/vfb_entry/12306/)
- [](https://www.libd.org/vfb_entry/12305/)
- [](https://www.libd.org/vfb_entry/12300/)
- [](https://www.libd.org/vfb_entry/12299/)
- [](https://www.libd.org/vfb_entry/12298/)
- [](https://www.libd.org/vfb_entry/12297/)
- [](https://www.libd.org/vfb_entry/12296/)
- [](https://www.libd.org/vfb_entry/12295/)
- [](https://www.libd.org/vfb_entry/12294/)
- [](https://www.libd.org/vfb_entry/12293/)
- [](https://www.libd.org/vfb_entry/12292/)
- [](https://www.libd.org/vfb_entry/12291/)
- [](https://www.libd.org/vfb_entry/12266/)
- [](https://www.libd.org/vfb_entry/12253/)
- [](https://www.libd.org/vfb_entry/12248/)
- [](https://www.libd.org/vfb_entry/12247/)
- [](https://www.libd.org/vfb_entry/12233/)
- [](https://www.libd.org/vfb_entry/12232/)
- [](https://www.libd.org/vfb_entry/12231/)
- [](https://www.libd.org/vfb_entry/12226/)
- [](https://www.libd.org/vfb_entry/12225/)
- [](https://www.libd.org/vfb_entry/12210/)
- [](https://www.libd.org/vfb_entry/12201/)
- [](https://www.libd.org/vfb_entry/12200/)
- [](https://www.libd.org/vfb_entry/12199/)
- [](https://www.libd.org/vfb_entry/12198/)
- [](https://www.libd.org/vfb_entry/12197/)
- [](https://www.libd.org/vfb_entry/12196/)
- [](https://www.libd.org/vfb_entry/12195/)
- [](https://www.libd.org/vfb_entry/12176/)
- [](https://www.libd.org/vfb_entry/12168/)
- [](https://www.libd.org/vfb_entry/12167/)
- [](https://www.libd.org/vfb_entry/12166/)
- [](https://www.libd.org/vfb_entry/12159/)
- [](https://www.libd.org/vfb_entry/12158/)
- [](https://www.libd.org/vfb_entry/12157/)
- [](https://www.libd.org/vfb_entry/12156/)
- [](https://www.libd.org/vfb_entry/12155/)
- [](https://www.libd.org/vfb_entry/12154/)
- [](https://www.libd.org/vfb_entry/12153/)
- [](https://www.libd.org/vfb_entry/12143/)
- [](https://www.libd.org/vfb_entry/12142/)
- [](https://www.libd.org/vfb_entry/12141/)
- [](https://www.libd.org/vfb_entry/12140/)
- [](https://www.libd.org/vfb_entry/12135/)
- [](https://www.libd.org/vfb_entry/12134/)
- [](https://www.libd.org/vfb_entry/12119/)
- [](https://www.libd.org/vfb_entry/12108/)
- [](https://www.libd.org/vfb_entry/12074/)
- [](https://www.libd.org/vfb_entry/12065/)
- [](https://www.libd.org/vfb_entry/12064/)
- [](https://www.libd.org/vfb_entry/12060/)
- [](https://www.libd.org/vfb_entry/12059/)
- [](https://www.libd.org/vfb_entry/12057/)
- [](https://www.libd.org/vfb_entry/12028/)
- [](https://www.libd.org/vfb_entry/11836/)
- [](https://www.libd.org/vfb_entry/11835/)
- [](https://www.libd.org/vfb_entry/11834/)
- [](https://www.libd.org/vfb_entry/11833/)
- [](https://www.libd.org/vfb_entry/11832/)
- [](https://www.libd.org/vfb_entry/11831/)
- [](https://www.libd.org/vfb_entry/11828/)
- [](https://www.libd.org/vfb_entry/11827/)
- [](https://www.libd.org/vfb_entry/11826/)
- [](https://www.libd.org/vfb_entry/11825/)
- [](https://www.libd.org/vfb_entry/11824/)
- [](https://www.libd.org/vfb_entry/11823/)
- [](https://www.libd.org/vfb_entry/11822/)
- [](https://www.libd.org/vfb_entry/11743/)
- [](https://www.libd.org/vfb_entry/11735/)
- [](https://www.libd.org/vfb_entry/11734/)
- [](https://www.libd.org/vfb_entry/11733/)
- [](https://www.libd.org/vfb_entry/11732/)
- [](https://www.libd.org/vfb_entry/11731/)
- [](https://www.libd.org/vfb_entry/11730/)
- [](https://www.libd.org/vfb_entry/11706/)
- [](https://www.libd.org/vfb_entry/11705/)
- [](https://www.libd.org/vfb_entry/11676/)
- [](https://www.libd.org/vfb_entry/11675/)
- [](https://www.libd.org/vfb_entry/11674/)
- [](https://www.libd.org/vfb_entry/11673/)
- [](https://www.libd.org/vfb_entry/11671/)
- [](https://www.libd.org/vfb_entry/11670/)
- [](https://www.libd.org/vfb_entry/11666/)
- [](https://www.libd.org/vfb_entry/11665/)
- [](https://www.libd.org/vfb_entry/11658/)
- [](https://www.libd.org/vfb_entry/11657/)
- [](https://www.libd.org/vfb_entry/11644/)
- [](https://www.libd.org/vfb_entry/11643/)
- [](https://www.libd.org/vfb_entry/11642/)
- [](https://www.libd.org/vfb_entry/11630/)
- [](https://www.libd.org/vfb_entry/11628/)
- [](https://www.libd.org/vfb_entry/11579/)
- [](https://www.libd.org/vfb_entry/11578/)
- [](https://www.libd.org/vfb_entry/11577/)
- [](https://www.libd.org/vfb_entry/11569/)
- [](https://www.libd.org/vfb_entry/11556/)
- [](https://www.libd.org/vfb_entry/11555/)
- [](https://www.libd.org/vfb_entry/11554/)
- [](https://www.libd.org/vfb_entry/11537/)
- [](https://www.libd.org/vfb_entry/11536/)
- [](https://www.libd.org/vfb_entry/11526/)
- [](https://www.libd.org/vfb_entry/11525/)
- [](https://www.libd.org/vfb_entry/11524/)
- [](https://www.libd.org/vfb_entry/11523/)
- [](https://www.libd.org/vfb_entry/11522/)
- [](https://www.libd.org/vfb_entry/11521/)
- [](https://www.libd.org/vfb_entry/11520/)
- [](https://www.libd.org/vfb_entry/11517/)
- [](https://www.libd.org/vfb_entry/11511/)
- [](https://www.libd.org/vfb_entry/11510/)
- [](https://www.libd.org/vfb_entry/11509/)
- [](https://www.libd.org/vfb_entry/11508/)
- [](https://www.libd.org/vfb_entry/11507/)
- [](https://www.libd.org/vfb_entry/11503/)
- [](https://www.libd.org/vfb_entry/11482/)
- [](https://www.libd.org/vfb_entry/11481/)
- [](https://www.libd.org/vfb_entry/11480/)
- [](https://www.libd.org/vfb_entry/11479/)
- [](https://www.libd.org/vfb_entry/11478/)
- [](https://www.libd.org/vfb_entry/11477/)
- [](https://www.libd.org/vfb_entry/11476/)
- [](https://www.libd.org/vfb_entry/11475/)
- [](https://www.libd.org/vfb_entry/11470/)
- [](https://www.libd.org/vfb_entry/11469/)
- [](https://www.libd.org/vfb_entry/11468/)
- [](https://www.libd.org/vfb_entry/11467/)
- [](https://www.libd.org/vfb_entry/11466/)
- [](https://www.libd.org/vfb_entry/11465/)
- [](https://www.libd.org/vfb_entry/11464/)
- [](https://www.libd.org/vfb_entry/11443/)
- [](https://www.libd.org/vfb_entry/11442/)
- [](https://www.libd.org/vfb_entry/11441/)
- [](https://www.libd.org/vfb_entry/11440/)
- [](https://www.libd.org/vfb_entry/11439/)
- [](https://www.libd.org/vfb_entry/11438/)
- [](https://www.libd.org/vfb_entry/11404/)
- [](https://www.libd.org/vfb_entry/11379/)
- [](https://www.libd.org/vfb_entry/11375/)
- [](https://www.libd.org/vfb_entry/11374/)
- [](https://www.libd.org/vfb_entry/11373/)
- [](https://www.libd.org/vfb_entry/11372/)
- [](https://www.libd.org/vfb_entry/11371/)
- [](https://www.libd.org/vfb_entry/11370/)
- [](https://www.libd.org/vfb_entry/11362/)
- [](https://www.libd.org/vfb_entry/11361/)
- [](https://www.libd.org/vfb_entry/11360/)
- [](https://www.libd.org/vfb_entry/11359/)
- [](https://www.libd.org/vfb_entry/11358/)
- [](https://www.libd.org/vfb_entry/11357/)
- [](https://www.libd.org/vfb_entry/11356/)
- [](https://www.libd.org/vfb_entry/11355/)
- [](https://www.libd.org/vfb_entry/11354/)
- [](https://www.libd.org/vfb_entry/11353/)
- [](https://www.libd.org/vfb_entry/11352/)
- [](https://www.libd.org/vfb_entry/11347/)
- [](https://www.libd.org/vfb_entry/11346/)
- [](https://www.libd.org/vfb_entry/11345/)
- [](https://www.libd.org/vfb_entry/11344/)
- [](https://www.libd.org/vfb_entry/11316/)
- [](https://www.libd.org/vfb_entry/11315/)
- [](https://www.libd.org/vfb_entry/11314/)
- [](https://www.libd.org/vfb_entry/11299/)
- [](https://www.libd.org/vfb_entry/11298/)
- [](https://www.libd.org/vfb_entry/11297/)
- [](https://www.libd.org/vfb_entry/11296/)
- [](https://www.libd.org/vfb_entry/11295/)
- [](https://www.libd.org/vfb_entry/11294/)
- [](https://www.libd.org/vfb_entry/11293/)
- [](https://www.libd.org/vfb_entry/11292/)
- [](https://www.libd.org/vfb_entry/11291/)
- [](https://www.libd.org/vfb_entry/11284/)
- [](https://www.libd.org/vfb_entry/11265/)
- [](https://www.libd.org/vfb_entry/11264/)
- [](https://www.libd.org/vfb_entry/11263/)
- [](https://www.libd.org/vfb_entry/11262/)
- [](https://www.libd.org/vfb_entry/11261/)
- [](https://www.libd.org/vfb_entry/11260/)
- [](https://www.libd.org/vfb_entry/11259/)
- [](https://www.libd.org/vfb_entry/11258/)
- [](https://www.libd.org/vfb_entry/11257/)
- [](https://www.libd.org/vfb_entry/11256/)
- [](https://www.libd.org/vfb_entry/11255/)
- [](https://www.libd.org/vfb_entry/11254/)
- [](https://www.libd.org/vfb_entry/11253/)
- [](https://www.libd.org/vfb_entry/11252/)
- [](https://www.libd.org/vfb_entry/11251/)
- [](https://www.libd.org/vfb_entry/11250/)
- [](https://www.libd.org/vfb_entry/11249/)
- [](https://www.libd.org/vfb_entry/11248/)
- [](https://www.libd.org/vfb_entry/11242/)
- [](https://www.libd.org/vfb_entry/11241/)
- [](https://www.libd.org/vfb_entry/11240/)
- [](https://www.libd.org/vfb_entry/11239/)
- [](https://www.libd.org/vfb_entry/11238/)
- [](https://www.libd.org/vfb_entry/11237/)
- [](https://www.libd.org/vfb_entry/11236/)
- [](https://www.libd.org/vfb_entry/11227/)
- [](https://www.libd.org/vfb_entry/11226/)
- [](https://www.libd.org/vfb_entry/11225/)
- [](https://www.libd.org/vfb_entry/11224/)
- [](https://www.libd.org/vfb_entry/11223/)
- [](https://www.libd.org/vfb_entry/11222/)
- [](https://www.libd.org/vfb_entry/11221/)
- [](https://www.libd.org/vfb_entry/11220/)
- [](https://www.libd.org/vfb_entry/11219/)
- [](https://www.libd.org/vfb_entry/11218/)
- [](https://www.libd.org/vfb_entry/11200/)
- [](https://www.libd.org/vfb_entry/11199/)
- [](https://www.libd.org/vfb_entry/11194/)
- [](https://www.libd.org/vfb_entry/11193/)
- [](https://www.libd.org/vfb_entry/11192/)
- [](https://www.libd.org/vfb_entry/11191/)
- [](https://www.libd.org/vfb_entry/11190/)
- [](https://www.libd.org/vfb_entry/11173/)
- [](https://www.libd.org/vfb_entry/11172/)
- [](https://www.libd.org/vfb_entry/11162/)
- [](https://www.libd.org/vfb_entry/11161/)
- [](https://www.libd.org/vfb_entry/11160/)
- [](https://www.libd.org/vfb_entry/11158/)
- [](https://www.libd.org/vfb_entry/11153/)
- [](https://www.libd.org/vfb_entry/11152/)
- [](https://www.libd.org/vfb_entry/11134/)
- [](https://www.libd.org/vfb_entry/11133/)
- [](https://www.libd.org/vfb_entry/11132/)
- [](https://www.libd.org/vfb_entry/11126/)
- [](https://www.libd.org/vfb_entry/11121/)
- [](https://www.libd.org/vfb_entry/11108/)
- [](https://www.libd.org/vfb_entry/11107/)
- [](https://www.libd.org/vfb_entry/11106/)
- [](https://www.libd.org/vfb_entry/11105/)
- [](https://www.libd.org/vfb_entry/11101/)
- [](https://www.libd.org/vfb_entry/11076/)
- [](https://www.libd.org/vfb_entry/11075/)
- [](https://www.libd.org/vfb_entry/11063/)
- [](https://www.libd.org/vfb_entry/11062/)
- [](https://www.libd.org/vfb_entry/11061/)
- [](https://www.libd.org/vfb_entry/11053/)
- [](https://www.libd.org/vfb_entry/11052/)
- [](https://www.libd.org/vfb_entry/11051/)
- [](https://www.libd.org/vfb_entry/11036/)
- [](https://www.libd.org/vfb_entry/11035/)
- [](https://www.libd.org/vfb_entry/11034/)
- [](https://www.libd.org/vfb_entry/11033/)
- [](https://www.libd.org/vfb_entry/10995/)
- [](https://www.libd.org/vfb_entry/10982/)
- [](https://www.libd.org/vfb_entry/10966/)
- [](https://www.libd.org/vfb_entry/10965/)
- [](https://www.libd.org/vfb_entry/10964/)
- [](https://www.libd.org/vfb_entry/10963/)
- [](https://www.libd.org/vfb_entry/10960/)
- [](https://www.libd.org/vfb_entry/10959/)
- [](https://www.libd.org/vfb_entry/10958/)
- [](https://www.libd.org/vfb_entry/10957/)
- [](https://www.libd.org/vfb_entry/10956/)
- [](https://www.libd.org/vfb_entry/10955/)
- [](https://www.libd.org/vfb_entry/10954/)
- [](https://www.libd.org/vfb_entry/10953/)
- [](https://www.libd.org/vfb_entry/10952/)
- [](https://www.libd.org/vfb_entry/10951/)
- [](https://www.libd.org/vfb_entry/10950/)
- [](https://www.libd.org/vfb_entry/10949/)
- [](https://www.libd.org/vfb_entry/10948/)
- [](https://www.libd.org/vfb_entry/10947/)
- [](https://www.libd.org/vfb_entry/10943/)
- [](https://www.libd.org/vfb_entry/10942/)
- [](https://www.libd.org/vfb_entry/10941/)
- [](https://www.libd.org/vfb_entry/10940/)
- [](https://www.libd.org/vfb_entry/10939/)
- [](https://www.libd.org/vfb_entry/10938/)
- [](https://www.libd.org/vfb_entry/10936/)
- [](https://www.libd.org/vfb_entry/10935/)
- [](https://www.libd.org/vfb_entry/10934/)
- [](https://www.libd.org/vfb_entry/10933/)
- [](https://www.libd.org/vfb_entry/10932/)
- [](https://www.libd.org/vfb_entry/10931/)
- [](https://www.libd.org/vfb_entry/10930/)
- [](https://www.libd.org/vfb_entry/10915/)
- [](https://www.libd.org/vfb_entry/10897/)
- [](https://www.libd.org/vfb_entry/10896/)
- [](https://www.libd.org/vfb_entry/10883/)
- [](https://www.libd.org/vfb_entry/10876/)
- [](https://www.libd.org/vfb_entry/10875/)
- [](https://www.libd.org/vfb_entry/10839/)
- [](https://www.libd.org/vfb_entry/10838/)
- [](https://www.libd.org/vfb_entry/10837/)
- [](https://www.libd.org/vfb_entry/10810/)
- [](https://www.libd.org/vfb_entry/10808/)
- [](https://www.libd.org/vfb_entry/10788/)
- [](https://www.libd.org/vfb_entry/10787/)
- [](https://www.libd.org/vfb_entry/10786/)
- [](https://www.libd.org/vfb_entry/10784/)
- [](https://www.libd.org/vfb_entry/10783/)
- [](https://www.libd.org/vfb_entry/10782/)
- [](https://www.libd.org/vfb_entry/10781/)
- [](https://www.libd.org/vfb_entry/10780/)
- [](https://www.libd.org/vfb_entry/10779/)
- [](https://www.libd.org/vfb_entry/10778/)
- [](https://www.libd.org/vfb_entry/10777/)
- [](https://www.libd.org/vfb_entry/10776/)
- [](https://www.libd.org/vfb_entry/10775/)
- [](https://www.libd.org/vfb_entry/10774/)
- [](https://www.libd.org/vfb_entry/10773/)
- [](https://www.libd.org/vfb_entry/10772/)
- [](https://www.libd.org/vfb_entry/10771/)
- [](https://www.libd.org/vfb_entry/10770/)
- [](https://www.libd.org/vfb_entry/10729/)
- [](https://www.libd.org/vfb_entry/10728/)
- [](https://www.libd.org/vfb_entry/10687/)
- [](https://www.libd.org/vfb_entry/10683/)
- [](https://www.libd.org/vfb_entry/10682/)
- [](https://www.libd.org/vfb_entry/10681/)
- [](https://www.libd.org/vfb_entry/10680/)
- [](https://www.libd.org/vfb_entry/10679/)
- [](https://www.libd.org/vfb_entry/10678/)
- [](https://www.libd.org/vfb_entry/10677/)
- [](https://www.libd.org/vfb_entry/10676/)
- [](https://www.libd.org/vfb_entry/10667/)
- [](https://www.libd.org/vfb_entry/10643/)
- [](https://www.libd.org/vfb_entry/10638/)
- [](https://www.libd.org/vfb_entry/10633/)
- [](https://www.libd.org/vfb_entry/10631/)
- [](https://www.libd.org/vfb_entry/10630/)
- [](https://www.libd.org/vfb_entry/10613/)
- [](https://www.libd.org/vfb_entry/10612/)
- [](https://www.libd.org/vfb_entry/10611/)
- [](https://www.libd.org/vfb_entry/10610/)
- [](https://www.libd.org/vfb_entry/10609/)
- [](https://www.libd.org/vfb_entry/10608/)
- [](https://www.libd.org/vfb_entry/10600/)
- [](https://www.libd.org/vfb_entry/10599/)
- [](https://www.libd.org/vfb_entry/10598/)
- [](https://www.libd.org/vfb_entry/10597/)
- [](https://www.libd.org/vfb_entry/10596/)
- [](https://www.libd.org/vfb_entry/10595/)
- [](https://www.libd.org/vfb_entry/10594/)
- [](https://www.libd.org/vfb_entry/10593/)
- [](https://www.libd.org/vfb_entry/10592/)
- [](https://www.libd.org/vfb_entry/10590/)
- [](https://www.libd.org/vfb_entry/10576/)
- [](https://www.libd.org/vfb_entry/10575/)
- [](https://www.libd.org/vfb_entry/10574/)
- [](https://www.libd.org/vfb_entry/10573/)
- [](https://www.libd.org/vfb_entry/10572/)
- [](https://www.libd.org/vfb_entry/10571/)
- [](https://www.libd.org/vfb_entry/10570/)
- [](https://www.libd.org/vfb_entry/10569/)
- [](https://www.libd.org/vfb_entry/10568/)
- [](https://www.libd.org/vfb_entry/10567/)
- [](https://www.libd.org/vfb_entry/10566/)
- [](https://www.libd.org/vfb_entry/10565/)
- [](https://www.libd.org/vfb_entry/10564/)
- [](https://www.libd.org/vfb_entry/10563/)
- [](https://www.libd.org/vfb_entry/10562/)
- [](https://www.libd.org/vfb_entry/10561/)
- [](https://www.libd.org/vfb_entry/10560/)
- [](https://www.libd.org/vfb_entry/10556/)
- [](https://www.libd.org/vfb_entry/10555/)
- [](https://www.libd.org/vfb_entry/10554/)
- [](https://www.libd.org/vfb_entry/10544/)
- [](https://www.libd.org/vfb_entry/10502/)
- [](https://www.libd.org/vfb_entry/10501/)
- [](https://www.libd.org/vfb_entry/10500/)
- [](https://www.libd.org/vfb_entry/10499/)
- [](https://www.libd.org/vfb_entry/10497/)
- [](https://www.libd.org/vfb_entry/10496/)
- [](https://www.libd.org/vfb_entry/10495/)
- [](https://www.libd.org/vfb_entry/10494/)
- [](https://www.libd.org/vfb_entry/10493/)
- [](https://www.libd.org/vfb_entry/10492/)
- [](https://www.libd.org/vfb_entry/10491/)
- [](https://www.libd.org/vfb_entry/10490/)
- [](https://www.libd.org/vfb_entry/10489/)
- [](https://www.libd.org/vfb_entry/10488/)
- [](https://www.libd.org/vfb_entry/10487/)
- [](https://www.libd.org/vfb_entry/10486/)
- [](https://www.libd.org/vfb_entry/10485/)
- [](https://www.libd.org/vfb_entry/10484/)
- [](https://www.libd.org/vfb_entry/10483/)
- [](https://www.libd.org/vfb_entry/10482/)
- [](https://www.libd.org/vfb_entry/10481/)
- [](https://www.libd.org/vfb_entry/10480/)
- [](https://www.libd.org/vfb_entry/10479/)
- [](https://www.libd.org/vfb_entry/10478/)
- [](https://www.libd.org/vfb_entry/10477/)
- [](https://www.libd.org/vfb_entry/10476/)
- [](https://www.libd.org/vfb_entry/10475/)
- [](https://www.libd.org/vfb_entry/10474/)
- [](https://www.libd.org/vfb_entry/10473/)
- [](https://www.libd.org/vfb_entry/10472/)
- [](https://www.libd.org/vfb_entry/10471/)
- [](https://www.libd.org/vfb_entry/10470/)
- [](https://www.libd.org/vfb_entry/10469/)
- [](https://www.libd.org/vfb_entry/10468/)
- [](https://www.libd.org/vfb_entry/10467/)
- [](https://www.libd.org/vfb_entry/10466/)
- [](https://www.libd.org/vfb_entry/10465/)
- [](https://www.libd.org/vfb_entry/10464/)
- [](https://www.libd.org/vfb_entry/10463/)
- [](https://www.libd.org/vfb_entry/10459/)
- [](https://www.libd.org/vfb_entry/10453/)
- [](https://www.libd.org/vfb_entry/10452/)
- [](https://www.libd.org/vfb_entry/10451/)
- [](https://www.libd.org/vfb_entry/10450/)
- [](https://www.libd.org/vfb_entry/10449/)
- [](https://www.libd.org/vfb_entry/10448/)
- [](https://www.libd.org/vfb_entry/10447/)
- [](https://www.libd.org/vfb_entry/10446/)
- [](https://www.libd.org/vfb_entry/10445/)
- [](https://www.libd.org/vfb_entry/10444/)
- [](https://www.libd.org/vfb_entry/10443/)
- [](https://www.libd.org/vfb_entry/10442/)
- [](https://www.libd.org/vfb_entry/10441/)
- [](https://www.libd.org/vfb_entry/10440/)
- [](https://www.libd.org/vfb_entry/10439/)
- [](https://www.libd.org/vfb_entry/10434/)
- [](https://www.libd.org/vfb_entry/10433/)
- [](https://www.libd.org/vfb_entry/10432/)
- [](https://www.libd.org/vfb_entry/10431/)
- [](https://www.libd.org/vfb_entry/10430/)
- [](https://www.libd.org/vfb_entry/10429/)
- [](https://www.libd.org/vfb_entry/10428/)
- [](https://www.libd.org/vfb_entry/10427/)
- [](https://www.libd.org/vfb_entry/10423/)
- [](https://www.libd.org/vfb_entry/10422/)
- [](https://www.libd.org/vfb_entry/10421/)
- [](https://www.libd.org/vfb_entry/10420/)
- [](https://www.libd.org/vfb_entry/10419/)
- [](https://www.libd.org/vfb_entry/10418/)
- [](https://www.libd.org/vfb_entry/10417/)
- [](https://www.libd.org/vfb_entry/10416/)
- [](https://www.libd.org/vfb_entry/10415/)
- [](https://www.libd.org/vfb_entry/10414/)
- [](https://www.libd.org/vfb_entry/10411/)
- [](https://www.libd.org/vfb_entry/10403/)
- [](https://www.libd.org/vfb_entry/10402/)
- [](https://www.libd.org/vfb_entry/10390/)
- [](https://www.libd.org/vfb_entry/10372/)
- [](https://www.libd.org/vfb_entry/10346/)
- [](https://www.libd.org/vfb_entry/10345/)
- [](https://www.libd.org/vfb_entry/10344/)
- [](https://www.libd.org/vfb_entry/10333/)
- [](https://www.libd.org/vfb_entry/10324/)
- [](https://www.libd.org/vfb_entry/10322/)
- [](https://www.libd.org/vfb_entry/10321/)
- [](https://www.libd.org/vfb_entry/10320/)
- [](https://www.libd.org/vfb_entry/10296/)
- [](https://www.libd.org/vfb_entry/10295/)
- [](https://www.libd.org/vfb_entry/10294/)
- [](https://www.libd.org/vfb_entry/10293/)
- [](https://www.libd.org/vfb_entry/10292/)
- [](https://www.libd.org/vfb_entry/10291/)
- [](https://www.libd.org/vfb_entry/10282/)
- [](https://www.libd.org/vfb_entry/10281/)
- [](https://www.libd.org/vfb_entry/10280/)
- [](https://www.libd.org/vfb_entry/10278/)
- [](https://www.libd.org/vfb_entry/10273/)
- [](https://www.libd.org/vfb_entry/10272/)
- [](https://www.libd.org/vfb_entry/10271/)
- [](https://www.libd.org/vfb_entry/10270/)
- [](https://www.libd.org/vfb_entry/10269/)
- [](https://www.libd.org/vfb_entry/10268/)
- [](https://www.libd.org/vfb_entry/10221/)
- [](https://www.libd.org/vfb_entry/10214/)
- [](https://www.libd.org/vfb_entry/10213/)
- [](https://www.libd.org/vfb_entry/10212/)
- [](https://www.libd.org/vfb_entry/10211/)
- [](https://www.libd.org/vfb_entry/10210/)
- [](https://www.libd.org/vfb_entry/10207/)
- [](https://www.libd.org/vfb_entry/10206/)
- [](https://www.libd.org/vfb_entry/10205/)
- [](https://www.libd.org/vfb_entry/10204/)
- [](https://www.libd.org/vfb_entry/10203/)
- [](https://www.libd.org/vfb_entry/10196/)
- [](https://www.libd.org/vfb_entry/10195/)
- [](https://www.libd.org/vfb_entry/10194/)
- [](https://www.libd.org/vfb_entry/10193/)
- [](https://www.libd.org/vfb_entry/10190/)
- [](https://www.libd.org/vfb_entry/10189/)
- [](https://www.libd.org/vfb_entry/10187/)
- [](https://www.libd.org/vfb_entry/10186/)
- [](https://www.libd.org/vfb_entry/10185/)
- [](https://www.libd.org/vfb_entry/10184/)
- [](https://www.libd.org/vfb_entry/10183/)
- [](https://www.libd.org/vfb_entry/10182/)
- [](https://www.libd.org/vfb_entry/10181/)
- [](https://www.libd.org/vfb_entry/10174/)
- [](https://www.libd.org/vfb_entry/10173/)
- [](https://www.libd.org/vfb_entry/10172/)
- [](https://www.libd.org/vfb_entry/10171/)
- [](https://www.libd.org/vfb_entry/10170/)
- [](https://www.libd.org/vfb_entry/10144/)
- [](https://www.libd.org/vfb_entry/10099/)
- [](https://www.libd.org/vfb_entry/10060/)
- [](https://www.libd.org/vfb_entry/10059/)
- [](https://www.libd.org/vfb_entry/10054/)
- [](https://www.libd.org/vfb_entry/10053/)
- [](https://www.libd.org/vfb_entry/10036/)
- [](https://www.libd.org/vfb_entry/10035/)
- [](https://www.libd.org/vfb_entry/10034/)
- [](https://www.libd.org/vfb_entry/10033/)
- [](https://www.libd.org/vfb_entry/10032/)
- [](https://www.libd.org/vfb_entry/10017/)
- [](https://www.libd.org/vfb_entry/10016/)
- [](https://www.libd.org/vfb_entry/10015/)
- [](https://www.libd.org/vfb_entry/10014/)
- [](https://www.libd.org/vfb_entry/10013/)
- [](https://www.libd.org/vfb_entry/10012/)
- [](https://www.libd.org/vfb_entry/10011/)
- [](https://www.libd.org/vfb_entry/10010/)
- [](https://www.libd.org/vfb_entry/10009/)
- [](https://www.libd.org/vfb_entry/10008/)
- [](https://www.libd.org/vfb_entry/10002/)
- [](https://www.libd.org/vfb_entry/9998/)
- [](https://www.libd.org/vfb_entry/9984/)
- [](https://www.libd.org/vfb_entry/9983/)
- [](https://www.libd.org/vfb_entry/9977/)
- [](https://www.libd.org/vfb_entry/9976/)
- [](https://www.libd.org/vfb_entry/9975/)
- [](https://www.libd.org/vfb_entry/9974/)
- [](https://www.libd.org/vfb_entry/9973/)
- [](https://www.libd.org/vfb_entry/9920/)
- [](https://www.libd.org/vfb_entry/9695/)
- [](https://www.libd.org/vfb_entry/9694/)
- [](https://www.libd.org/vfb_entry/9692/)
- [](https://www.libd.org/vfb_entry/9691/)
- [](https://www.libd.org/vfb_entry/9690/)
- [](https://www.libd.org/vfb_entry/9689/)
- [](https://www.libd.org/vfb_entry/9688/)
- [](https://www.libd.org/vfb_entry/9681/)
- [](https://www.libd.org/vfb_entry/9639/)
- [](https://www.libd.org/vfb_entry/9607/)
- [](https://www.libd.org/vfb_entry/9606/)
- [](https://www.libd.org/vfb_entry/8089/)
- [](https://www.libd.org/vfb_entry/8088/)
- [](https://www.libd.org/vfb_entry/8087/)
- [](https://www.libd.org/vfb_entry/8086/)
- [](https://www.libd.org/vfb_entry/8085/)
- [](https://www.libd.org/vfb_entry/8079/)
- [](https://www.libd.org/vfb_entry/8065/)
- [](https://www.libd.org/vfb_entry/8064/)
- [](https://www.libd.org/vfb_entry/8063/)
- [](https://www.libd.org/vfb_entry/8062/)
- [](https://www.libd.org/vfb_entry/8061/)
- [](https://www.libd.org/vfb_entry/8060/)
- [](https://www.libd.org/vfb_entry/8059/)
- [](https://www.libd.org/vfb_entry/8058/)
- [](https://www.libd.org/vfb_entry/8057/)
- [](https://www.libd.org/vfb_entry/8056/)
- [](https://www.libd.org/vfb_entry/8055/)
- [](https://www.libd.org/vfb_entry/8052/)
- [](https://www.libd.org/vfb_entry/8051/)
- [](https://www.libd.org/vfb_entry/8050/)
- [](https://www.libd.org/vfb_entry/8049/)
- [](https://www.libd.org/vfb_entry/8044/)
- [](https://www.libd.org/vfb_entry/8043/)
- [](https://www.libd.org/vfb_entry/8042/)
- [](https://www.libd.org/vfb_entry/8039/)
- [](https://www.libd.org/vfb_entry/8038/)
- [](https://www.libd.org/vfb_entry/8018/)
- [](https://www.libd.org/vfb_entry/8017/)
- [](https://www.libd.org/vfb_entry/8016/)
- [](https://www.libd.org/vfb_entry/8015/)
- [](https://www.libd.org/vfb_entry/8014/)
- [](https://www.libd.org/vfb_entry/8013/)
- [](https://www.libd.org/vfb_entry/8012/)
- [](https://www.libd.org/vfb_entry/8011/)
- [](https://www.libd.org/vfb_entry/8010/)
- [](https://www.libd.org/vfb_entry/8009/)
- [](https://www.libd.org/vfb_entry/8008/)
- [](https://www.libd.org/vfb_entry/8007/)
- [](https://www.libd.org/vfb_entry/8006/)
- [](https://www.libd.org/vfb_entry/8005/)
- [](https://www.libd.org/vfb_entry/8004/)
- [](https://www.libd.org/vfb_entry/8003/)
- [](https://www.libd.org/vfb_entry/8000/)
- [](https://www.libd.org/vfb_entry/7999/)
- [](https://www.libd.org/vfb_entry/7998/)
- [](https://www.libd.org/vfb_entry/7997/)
- [](https://www.libd.org/vfb_entry/7996/)
- [](https://www.libd.org/vfb_entry/7995/)
- [](https://www.libd.org/vfb_entry/7993/)
- [](https://www.libd.org/vfb_entry/7985/)
- [](https://www.libd.org/vfb_entry/7984/)
- [](https://www.libd.org/vfb_entry/7983/)
- [](https://www.libd.org/vfb_entry/7982/)
- [](https://www.libd.org/vfb_entry/7981/)
- [](https://www.libd.org/vfb_entry/7980/)
- [](https://www.libd.org/vfb_entry/7972/)
- [](https://www.libd.org/vfb_entry/7970/)
- [](https://www.libd.org/vfb_entry/7968/)
- [](https://www.libd.org/vfb_entry/7967/)
- [](https://www.libd.org/vfb_entry/7966/)
- [](https://www.libd.org/vfb_entry/7965/)
- [](https://www.libd.org/vfb_entry/7964/)
- [](https://www.libd.org/vfb_entry/7963/)
- [](https://www.libd.org/vfb_entry/7962/)
- [](https://www.libd.org/vfb_entry/7961/)
- [](https://www.libd.org/vfb_entry/7959/)
- [](https://www.libd.org/vfb_entry/7958/)
- [](https://www.libd.org/vfb_entry/7957/)
- [](https://www.libd.org/vfb_entry/7956/)
- [](https://www.libd.org/vfb_entry/7955/)
- [](https://www.libd.org/vfb_entry/7954/)
- [](https://www.libd.org/vfb_entry/7953/)
- [](https://www.libd.org/vfb_entry/7952/)
- [](https://www.libd.org/vfb_entry/7951/)
- [](https://www.libd.org/vfb_entry/7950/)
- [](https://www.libd.org/vfb_entry/7949/)
- [](https://www.libd.org/vfb_entry/7945/)
- [](https://www.libd.org/vfb_entry/7944/)
- [](https://www.libd.org/vfb_entry/7942/)
- [](https://www.libd.org/vfb_entry/7940/)
- [](https://www.libd.org/vfb_entry/7939/)
- [](https://www.libd.org/vfb_entry/7932/)
- [](https://www.libd.org/vfb_entry/7927/)
- [](https://www.libd.org/vfb_entry/7913/)
- [](https://www.libd.org/vfb_entry/7912/)
- [](https://www.libd.org/vfb_entry/7911/)
- [](https://www.libd.org/vfb_entry/7910/)
- [](https://www.libd.org/vfb_entry/7909/)
- [](https://www.libd.org/vfb_entry/7908/)
- [](https://www.libd.org/vfb_entry/7904/)
- [](https://www.libd.org/vfb_entry/7903/)
- [](https://www.libd.org/vfb_entry/7902/)
- [](https://www.libd.org/vfb_entry/7896/)
- [](https://www.libd.org/vfb_entry/7892/)
- [](https://www.libd.org/vfb_entry/7889/)
- [](https://www.libd.org/vfb_entry/7888/)
- [](https://www.libd.org/vfb_entry/7887/)
- [](https://www.libd.org/vfb_entry/7886/)
- [](https://www.libd.org/vfb_entry/7885/)
- [](https://www.libd.org/vfb_entry/7884/)
- [](https://www.libd.org/vfb_entry/7883/)
- [](https://www.libd.org/vfb_entry/7882/)
- [](https://www.libd.org/vfb_entry/7881/)
- [](https://www.libd.org/vfb_entry/7874/)
- [](https://www.libd.org/vfb_entry/7872/)
- [](https://www.libd.org/vfb_entry/7870/)
- [](https://www.libd.org/vfb_entry/7869/)
- [](https://www.libd.org/vfb_entry/7868/)
- [](https://www.libd.org/vfb_entry/7867/)
- [](https://www.libd.org/vfb_entry/7866/)
- [](https://www.libd.org/vfb_entry/7865/)
- [](https://www.libd.org/vfb_entry/7864/)
- [](https://www.libd.org/vfb_entry/7863/)
- [](https://www.libd.org/vfb_entry/7862/)
- [](https://www.libd.org/vfb_entry/7861/)
- [](https://www.libd.org/vfb_entry/7860/)
- [](https://www.libd.org/vfb_entry/7859/)
- [](https://www.libd.org/vfb_entry/7858/)
- [](https://www.libd.org/vfb_entry/7857/)
- [](https://www.libd.org/vfb_entry/7849/)
- [](https://www.libd.org/vfb_entry/7848/)
- [](https://www.libd.org/vfb_entry/7847/)
- [](https://www.libd.org/vfb_entry/7845/)
- [](https://www.libd.org/vfb_entry/7840/)
- [](https://www.libd.org/vfb_entry/7836/)
- [](https://www.libd.org/vfb_entry/7826/)
- [](https://www.libd.org/vfb_entry/7825/)
- [](https://www.libd.org/vfb_entry/7824/)
- [](https://www.libd.org/vfb_entry/7822/)
- [](https://www.libd.org/vfb_entry/7821/)
- [](https://www.libd.org/vfb_entry/7820/)
- [](https://www.libd.org/vfb_entry/7819/)
- [](https://www.libd.org/vfb_entry/7817/)
- [](https://www.libd.org/vfb_entry/7816/)
- [](https://www.libd.org/vfb_entry/7815/)
- [](https://www.libd.org/vfb_entry/7814/)
- [](https://www.libd.org/vfb_entry/7807/)
- [](https://www.libd.org/vfb_entry/7806/)
- [](https://www.libd.org/vfb_entry/7805/)
- [](https://www.libd.org/vfb_entry/7804/)
- [](https://www.libd.org/vfb_entry/7803/)
- [](https://www.libd.org/vfb_entry/7798/)
- [](https://www.libd.org/vfb_entry/7795/)
- [](https://www.libd.org/vfb_entry/7794/)
- [](https://www.libd.org/vfb_entry/7793/)
- [](https://www.libd.org/vfb_entry/7792/)
- [](https://www.libd.org/vfb_entry/7791/)
- [](https://www.libd.org/vfb_entry/7790/)
- [](https://www.libd.org/vfb_entry/7786/)
- [](https://www.libd.org/vfb_entry/7776/)
- [](https://www.libd.org/vfb_entry/7775/)
- [](https://www.libd.org/vfb_entry/7774/)
- [](https://www.libd.org/vfb_entry/7773/)
- [](https://www.libd.org/vfb_entry/7770/)
- [](https://www.libd.org/vfb_entry/7765/)
- [](https://www.libd.org/vfb_entry/7763/)
- [](https://www.libd.org/vfb_entry/7762/)
- [](https://www.libd.org/vfb_entry/7761/)
- [](https://www.libd.org/vfb_entry/7760/)
- [](https://www.libd.org/vfb_entry/7759/)
- [](https://www.libd.org/vfb_entry/7755/)
- [](https://www.libd.org/vfb_entry/7752/)
- [](https://www.libd.org/vfb_entry/7744/)
- [](https://www.libd.org/vfb_entry/7743/)
- [](https://www.libd.org/vfb_entry/7742/)
- [](https://www.libd.org/vfb_entry/7741/)
- [](https://www.libd.org/vfb_entry/7740/)
- [](https://www.libd.org/vfb_entry/7739/)
- [](https://www.libd.org/vfb_entry/7738/)
- [](https://www.libd.org/vfb_entry/7737/)
- [](https://www.libd.org/vfb_entry/7736/)
- [](https://www.libd.org/vfb_entry/7726/)
- [](https://www.libd.org/vfb_entry/7725/)
- [](https://www.libd.org/vfb_entry/7724/)
- [](https://www.libd.org/vfb_entry/7723/)
- [](https://www.libd.org/vfb_entry/7722/)
- [](https://www.libd.org/vfb_entry/7721/)
- [](https://www.libd.org/vfb_entry/7720/)
- [](https://www.libd.org/vfb_entry/7719/)
- [](https://www.libd.org/vfb_entry/7716/)
- [](https://www.libd.org/vfb_entry/7715/)
- [](https://www.libd.org/vfb_entry/7714/)
- [](https://www.libd.org/vfb_entry/7713/)
- [](https://www.libd.org/vfb_entry/7712/)
- [](https://www.libd.org/vfb_entry/7711/)
- [](https://www.libd.org/vfb_entry/7710/)
- [](https://www.libd.org/vfb_entry/7709/)
- [](https://www.libd.org/vfb_entry/7708/)
- [](https://www.libd.org/vfb_entry/7707/)
- [](https://www.libd.org/vfb_entry/7706/)
- [](https://www.libd.org/vfb_entry/7705/)
- [](https://www.libd.org/vfb_entry/7704/)
- [](https://www.libd.org/vfb_entry/7702/)
- [](https://www.libd.org/vfb_entry/7701/)
- [](https://www.libd.org/vfb_entry/7695/)
- [](https://www.libd.org/vfb_entry/7694/)
- [](https://www.libd.org/vfb_entry/7693/)
- [](https://www.libd.org/vfb_entry/7692/)
- [](https://www.libd.org/vfb_entry/7685/)
- [](https://www.libd.org/vfb_entry/7684/)
- [](https://www.libd.org/vfb_entry/7683/)
- [](https://www.libd.org/vfb_entry/7682/)
- [](https://www.libd.org/vfb_entry/7681/)
- [](https://www.libd.org/vfb_entry/7680/)
- [](https://www.libd.org/vfb_entry/7679/)
- [](https://www.libd.org/vfb_entry/7678/)
- [](https://www.libd.org/vfb_entry/7677/)
- [](https://www.libd.org/vfb_entry/7676/)
- [](https://www.libd.org/vfb_entry/7675/)
- [](https://www.libd.org/vfb_entry/7674/)
- [](https://www.libd.org/vfb_entry/7673/)
- [](https://www.libd.org/vfb_entry/7663/)
- [](https://www.libd.org/vfb_entry/7613/)
- [](https://www.libd.org/vfb_entry/7610/)
- [](https://www.libd.org/vfb_entry/7605/)
- [](https://www.libd.org/vfb_entry/7604/)
- [](https://www.libd.org/vfb_entry/7603/)
- [](https://www.libd.org/vfb_entry/7600/)
- [](https://www.libd.org/vfb_entry/7599/)
- [](https://www.libd.org/vfb_entry/7598/)
- [](https://www.libd.org/vfb_entry/7597/)
- [](https://www.libd.org/vfb_entry/7596/)
- [](https://www.libd.org/vfb_entry/7595/)
- [](https://www.libd.org/vfb_entry/7594/)
- [](https://www.libd.org/vfb_entry/7593/)
- [](https://www.libd.org/vfb_entry/7591/)
- [](https://www.libd.org/vfb_entry/7590/)
- [](https://www.libd.org/vfb_entry/7589/)
- [](https://www.libd.org/vfb_entry/7588/)
- [](https://www.libd.org/vfb_entry/7587/)
- [](https://www.libd.org/vfb_entry/7586/)
- [](https://www.libd.org/vfb_entry/7577/)
- [](https://www.libd.org/vfb_entry/7576/)
- [](https://www.libd.org/vfb_entry/7564/)
- [](https://www.libd.org/vfb_entry/7563/)
- [](https://www.libd.org/vfb_entry/7562/)
- [](https://www.libd.org/vfb_entry/7559/)
- [](https://www.libd.org/vfb_entry/7558/)
- [](https://www.libd.org/vfb_entry/7549/)
- [](https://www.libd.org/vfb_entry/7548/)
- [](https://www.libd.org/vfb_entry/7547/)
- [](https://www.libd.org/vfb_entry/7546/)
- [](https://www.libd.org/vfb_entry/7545/)
- [](https://www.libd.org/vfb_entry/7542/)
- [](https://www.libd.org/vfb_entry/7532/)
- [](https://www.libd.org/vfb_entry/7531/)
- [](https://www.libd.org/vfb_entry/7529/)
- [](https://www.libd.org/vfb_entry/7526/)
- [](https://www.libd.org/vfb_entry/7525/)
- [](https://www.libd.org/vfb_entry/7524/)
- [](https://www.libd.org/vfb_entry/7523/)
- [](https://www.libd.org/vfb_entry/7522/)
- [](https://www.libd.org/vfb_entry/7521/)
- [](https://www.libd.org/vfb_entry/7520/)
- [](https://www.libd.org/vfb_entry/7519/)
- [](https://www.libd.org/vfb_entry/7514/)
- [](https://www.libd.org/vfb_entry/7512/)
- [](https://www.libd.org/vfb_entry/7511/)
- [](https://www.libd.org/vfb_entry/7510/)
- [](https://www.libd.org/vfb_entry/7509/)
- [](https://www.libd.org/vfb_entry/7508/)
- [](https://www.libd.org/vfb_entry/7507/)
- [](https://www.libd.org/vfb_entry/7506/)
- [](https://www.libd.org/vfb_entry/7505/)

## Team

- [Gianluca-Ursini-MD-PhD](https://www.libd.org/team/gianluca-ursini-md-phd/)
- [Ye-Li-MD-PhD](https://www.libd.org/team/ye-li-md-phd/)
- [Marcus-Fernald](https://www.libd.org/team/marcus-fernald/)
- [Stephanie-Cerceo-Page-PhD](https://www.libd.org/team/stephanie-cerceo-page-phd/)
- [Sarah-Maguire-PhD](https://www.libd.org/team/sarah-maguire-phd/)
- [Caitlin-Bourne](https://www.libd.org/team/caitlin-bourne/)
- [Gregory-House](https://www.libd.org/team/gregory-house/)
- [Sara-Stump](https://www.libd.org/team/sara-stump/)
- [Pablo-de-Leon](https://www.libd.org/team/pablo-de-leon/)
- [Mike-Poslusney](https://www.libd.org/team/mike-poslusney/)
- [Sarah-Torres](https://www.libd.org/team/sarah-torres/)
- [Ingrid-Buchler](https://www.libd.org/team/ingrid-buchler/)
- [-](https://www.libd.org/team/jean-dubose/)
- [Madeline-Abramson](https://www.libd.org/team/madeline-abramson/)
- [Rayan-Abdelaziz](https://www.libd.org/team/rayan-abdelaziz/)
- [James-Barrow-PhD](https://www.libd.org/team/james-barrow-phd/)
- [Keri-Martinowich-PhD](https://www.libd.org/team/keri-martinowich-phd/)
- [Jorge-Miranda-Barrientos](https://www.libd.org/team/jorge-miranda-barrientos/)
- [Mariana-Alves](https://www.libd.org/team/mariana-alves/)
- [Oluwaseyi-Abujade](https://www.libd.org/team/oluwaseyi-abujade/)
- [Joseph-Bohlen](https://www.libd.org/team/joseph-bohlen/)
- [Jonathan-Werner-PhD-](https://www.libd.org/team/jonathan-werner-phd-/)
- [Lucas-Calderon](https://www.libd.org/team/lucas-calderon/)
- [Xavier-Sciarillo](https://www.libd.org/team/xavier-sciarillo/)
- [John-Randall](https://www.libd.org/team/john-randall/)
- [Adam-Howell](https://www.libd.org/team/adam-howell/)
- [Michael-Nagle-PhD](https://www.libd.org/team/michael-nagle-phd/)
- [Frank-Piscotta-PhD](https://www.libd.org/team/frank-piscotta-phd/)
- [Jennifer-Kim](https://www.libd.org/team/jennifer-kim/)
- [Raul-Garcia](https://www.libd.org/team/raul-garcia/)
- [Felix-Siewe](https://www.libd.org/team/felix-siewe/)
- [Kiersten-Hoffmann](https://www.libd.org/team/kiersten-hoffmann/)
- [Taylor-Dunham](https://www.libd.org/team/taylor-dunham/)
- [Geo-Pertea](https://www.libd.org/team/geo-pertea/)
- [Debamitra-Das-PhD](https://www.libd.org/team/debamitra-das-phd/)
- [Federica-Farinelli-PhD](https://www.libd.org/team/federica-farinelli-phd/)
- [Kristen-Maynard-PhD](https://www.libd.org/team/kristen-maynard-phd/)
- [Joseph-Johnson](https://www.libd.org/team/joseph-johnson/)
- [Svitlana-Bach-PhD](https://www.libd.org/team/svitlana-bach-phd/)
- [Donte-Owens-](https://www.libd.org/team/donte-owens-/) - Donte-Owens-
- [Thomas-M-Hyde-MD-PhD](https://www.libd.org/team/thomas-m-hyde-md-phd/)
- [Shizhong-Han-PhD](https://www.libd.org/team/shizhong-han-phd/)
- [Leonardo-Collado-Torres-PhD](https://www.libd.org/team/leonardo-collado-torres-phd/)
- [Dongsan-Kim-PhD](https://www.libd.org/team/dongsan-kim-phd/)
- [Gina-Shim](https://www.libd.org/team/gina-shim/)
- [Manisha-Barse](https://www.libd.org/team/manisha-barse/)
- [Joo-Heon-Shin-PhD](https://www.libd.org/team/joo-heon-shin-phd/)
- [Anandita-Rajpurohit](https://www.libd.org/team/anandita-rajpurohit/)
- [Aaron-Goldman](https://www.libd.org/team/aaron-goldman/)
- [Yifang-Francis-Huang](https://www.libd.org/team/yifang-francis-huang/)
- [Joel-Kleinman-MD-PhD](https://www.libd.org/team/joel-kleinman-md-phd/)
- [Chao-Li-PhD](https://www.libd.org/team/chao-li-phd/)
- [Gangling-Liao-PhD](https://www.libd.org/team/gangling-liao-phd/)
- [Brady-Maher-PhD](https://www.libd.org/team/brady-maher-phd/)
- [Eugenia-Radulescu-MD-PhD](https://www.libd.org/team/eugenia-radulescu-md-phd/)
- [Ran-Tao-PhD](https://www.libd.org/team/ran-tao-phd/)
- [Bill-Ulrich](https://www.libd.org/team/bill-ulrich/)
- [Yanhong-Wang-MD](https://www.libd.org/team/yanhong-wang-md/)
- [Andrew-Maslan-CPA](https://www.libd.org/team/andrew-maslan-cpa/)
- [Daniel-Weinberger-MD](https://www.libd.org/team/daniel-weinberger-md/) - Daniel R. Weinberger, M.D. is the Director & CEO of the Lieber Institute for Brain Development and considered a preeminent scientist in schizophrenia research.
- [Giovanna-Punzi-MD-PhD](https://www.libd.org/team/giovanna-punzi-md-phd/)
- [Madhavi-Tippani](https://www.libd.org/team/madhavi-tippani/)
- [Rebecca-Freedman](https://www.libd.org/team/rebecca-freedman/) - Chief Legal Officer Lieber Institute for Brain Development
- [Melissa-Barney](https://www.libd.org/team/melissa-barney/)
- [August-Deacon](https://www.libd.org/team/august-deacon/)
- [Francesca-Catlin](https://www.libd.org/team/francesca-catlin/)
- [Tomoyo-Sawada-PhD](https://www.libd.org/team/tomoyo-sawada-phd/)
- [James-Tooke](https://www.libd.org/team/james-tooke/)
- [Kelsey-Montgomery](https://www.libd.org/team/kelsey-montgomery/)
- [Louise-Huuki](https://www.libd.org/team/louise-huuki/)
- [Jiyun-Zhou-PhD](https://www.libd.org/team/jiyun-zhou-phd/)
- [Alejandra-Romero-Morales](https://www.libd.org/team/alejandra-romero-morales/)
- [Nick-Eagles](https://www.libd.org/team/nick-eagles/)
- [Daming-Chen](https://www.libd.org/team/daming-chen/)
- [Taeyoung-Hwang-PhD](https://www.libd.org/team/taeyoung-hwang-phd/)
- [Jisu-Ha-PhD](https://www.libd.org/team/jisu-ha-phd/)
- [Jiyoung-Kim-PhD](https://www.libd.org/team/jiyoung-kim-phd/)
- [Mark-McKinney](https://www.libd.org/team/mark-mckinney/)
- [Alejandra-McCord](https://www.libd.org/team/alejandra-mccord/)
- [Giulio-Pergola-PhD](https://www.libd.org/team/giulio-pergola-phd/)
- [Michael-Totty-PhD](https://www.libd.org/team/michael-totty-phd/)
- [Evgeny-Shlevkov](https://www.libd.org/team/evgeny-shlevkov/)
- [Heejin-Lee](https://www.libd.org/team/heejin-lee/)
- [Arun-Patil-PhD](https://www.libd.org/team/arun-patil-phd/)
- [Ryan-Miller](https://www.libd.org/team/ryan-miller/)
- [Jason-Rehg](https://www.libd.org/team/jason-rehg/)
- [Rachel-Orr-PsyD](https://www.libd.org/team/rachel-orr-psyd/)
- [Robert-Phillips-PhD](https://www.libd.org/team/robert-phillips-phd/)
- [Christopher-Borcuk](https://www.libd.org/team/christopher-borcuk/)
- [Vamshi-Mallepalli-MSc](https://www.libd.org/team/vamshi-mallepalli-msc/)
- [Jeanette-Stoltzfus](https://www.libd.org/team/jeanette-stoltzfus/)
- [Jehoon-Seo](https://www.libd.org/team/jehoon-seo/)
- [Daniel-Olivares](https://www.libd.org/team/daniel-olivares/)
- [Ishbel-Del-Rosario](https://www.libd.org/team/ishbel-del-rosario/)
- [Sharron-Evans](https://www.libd.org/team/sharron-evans/)
- [Joshua-Watterson](https://www.libd.org/team/joshua-watterson/)
- [Glen-Ernst](https://www.libd.org/team/glen-ernst/)
- [Michael-DePasquale](https://www.libd.org/team/michael-depasquale/)
- [Amy-Deep-Soboslay](https://www.libd.org/team/amy-deep-soboslay/)
- [Gregory-Carr-PhD](https://www.libd.org/team/gregory-carr-phd/)
- [Anna-Brandtjen](https://www.libd.org/team/anna-brandtjen/)
- [Rahul-Bharadwaj-PhD](https://www.libd.org/team/rahul-bharadwaj-phd/)
- [Solomon-Snyder-MD](https://www.libd.org/team/solomon-snyder-md/)
- [Aimee-Ormond](https://www.libd.org/team/aimee-ormond/)
- [Haya-AlGrain-PhD](https://www.libd.org/team/haya-algrain-phd/)

## Events

- [LIBD Seminar Series: Jing (Crystal) Zhao, Ph.D.](https://www.libd.org/events/libd-seminar-series-jing-crystal-zhao-ph-d/) - Role of RNA modification in stem cells Jing (Crystal) Zhao, Ph.D. Associate Professor Sanford Burnham Prebys Medical Discovery Institute When: December 1, 2020 2:00pm-3:00pm
- [LIBD Speaker Series: Michael Gandal, M.D., Ph.D.](https://www.libd.org/events/libd-speaker-series-michael-gandal-m-d-ph-d/) - "Human brain functional genomic characterization of the molecular mechanisms underlying genetic risk for schizophrenia" Michael Gandal, M.D., Ph.D. Assistant Professor, Psychiatry and Biobehavioral Sciences The Gandal Lab UCLA Semel Institute for Neuroscience and Human Behavior When: November 10, 2020 2:00pm-3:00pm
- [LIBD Speaker Series: Alexis Battle, Ph.D.](https://www.libd.org/events/libd-speaker-series-alexis-battle-ph-d/) - The dynamic impact of rare and common genetic variation from gene regulation to disease Alexis Battle, Ph.D. JHU, Whiting School of Engineering Dept. of Biomedical Engineering When: October 12, 2020 2:00pm-3:00pm
- [LIBD Speaker Series: Jonah Chan, Ph.D.](https://www.libd.org/events/libd-speaker-series-jonah-chan-ph-d/) - Experience-Dependent Myelination: Neuropeptides as Axonal Signals for Oligodendrocyte Differentiation and Myelination Jonah Chan, Ph.D. Rachleff Professor of Neurology UCSF Weill Institute for Neurosciences When: October 6, 2020 2:00pm-3:00pm
- [LIBD Speaker Series: Reza Kalhor, Ph.D.](https://www.libd.org/events/libd-speaker-series-reza-kalhor-ph-d/) - “Lineage mapping by genomic barcoding in the mouse” Reza Kalhor, Ph.D. Assistant Professor Biomedical Engineering Johns Hopkins University When: March 10, 2020 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Jeremy J. Day Ph.D.](https://www.libd.org/events/libd-speaker-series-jeremy-j-day-ph-d/) - “Control-Alter-Delete: Gene Regulatory Mechanisms in Brain Reward Circuitry” Jeremy J. Day, Ph.D. Associate Professor Department of Neurobiology Evelyn F. McKnight Brain Institute & The University of Alabama at Birmingham When: February 11, 2020 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Todd MacFarlan Ph.D.](https://www.libd.org/events/libd-speaker-series-todd-macfarlan-ph-d/) - “Co-evolution of a dual-histone H3 methyltransferase and its reader controls patterns of meiotic recombination” Todd MacFarlan, Ph.D. Principal Investigator Unit on Mammalian Epigenome Reprogramming National Institute of Health When: January 21, 2020 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Patricia H. Janak, Ph.D.](https://www.libd.org/events/libd-speaker-series-patricia-h-janak-ph-d/) - “Defining contributions of dopamine and striatal circuits to learning” Patricia H. Janak, Ph.D. Bloomberg Distinguished Professor Department of Psychological & Brain Sciences, Krieger School of Arts and Sciences Department of Neuroscience, Johns Hopkins School of Medicine When: November 12 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855
- [LIBD Speaker Series: Nathaniel Heintz, Ph.D.](https://www.libd.org/events/libd-speaker-series-nathaniel-heintz-ph-d/) - “Cell Types, Circuits and CNS Therapies” Nathaniel Heintz, Ph.D. James and Marilyn Simons Professor at the Rockefeller University, and an Investigator of The Howard Hughes Medical Institute When: October 15th 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Olga Troyanskaya, Ph.D.](https://www.libd.org/events/libd-speaker-series-olga-troyanskaya-ph-d/) - “Decoding the genome: data-driven modeling for molecular-level understanding of the brain” Olga Troyanskaya, Ph.D. Professor, Lewis-Sigler Institute for Integrative Genomics and the Department of Computer Science at Princeton University When: September 10 1:00pm-2:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Jordan W. Smoller, M.D., Sc.D.](https://www.libd.org/events/libd-speaker-series-jordan-w-smoller-m-d-sc-d/) - “Genomics, Phenomics and Precision Psychiatry” Jordan W. Smoller, M.D., Sc.D Director, Psychiatric and Neurodevelopmental Genetics Unit, MGH Center for Genomic Medicine When: September 24 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [More events coming soon!](https://www.libd.org/events/more-events-coming-soon/)
- [LIBD Speaker Series: Simon Kasif, Ph.D.](https://www.libd.org/events/libd-speaker-series-simon-kasif-ph-d/) - “Towards a Biological Network of Wellness and Disease Prevention” Simon Kasif, Ph.D. Professor of Biomedical Engineering, Bioinformatics and Computer Science in the Department of Biomedical Engineering at Boston University When: June 25 11:00am-12:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Jonathan Pritchard, Ph.D.](https://www.libd.org/events/libd-speaker-series-jonathan-pritchard-ph-d/) - The Omnigenic architecture of human complex traits. Jonathan Pritchard, Ph.D. Professor, Departments of Biology and Genetics, Stanford University Investigator, Howard Hughes Medical Institute When: December 7 11:00am-12:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [2019 Constance Lieber Prize](https://www.libd.org/events/2019-constance-lieber-prize/) - 2019 Constance Lieber Prize for Innovation in Developmental Neuroscience When: June 19, 2019 2:00pm-3:00pm Where: The Johns Hopkins Hospital Baltimore, MD More Info: libd.org/CLPrize
- [Autism Scientific Symposium](https://www.libd.org/events/autism-scientific-symposium/) - Marking 75 Years since Leo Kanner first identified autism
- [LIBD Speaker Series: Dara S. Manoach, Ph.D.](https://www.libd.org/events/libd-speaker-series-dara-s-manoach-ph-d/) - Reduced Sleep Spindles in Schizophrenia: A Treatable Endophenotype that Links Risk Genes to Impaired Cognition Dara S. Manoach, Ph.D. Professor of Psychology, Department of Psychiatry Massachusetts General Hospital, Harvard Medical School Athinoula A. Martinos Center for Biomedical Imaging When: August 2 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite
- [LIBD Speaker Series: Matthew A Wright, M.D., Ph.D.](https://www.libd.org/events/libd-speaker-series-matthew-a-wright-m-d-ph-d/) - Mapping transcription and long-range connectivity in intact neural volumes. Matthew A Wright, M.D., Ph.D. Instructor, Department of Psychiatry Postdoctoral Fellow, Deisseroth Lab Stanford University When: June 12 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Translating Placental Biology into Child Development](https://www.libd.org/events/translating-placental-biology-into-child-development/) - A one-day symposium event, May 4th, 2018 at the Johns Hopkins Bloomberg School of Public Health.
- [LIBD Speaker Series: Andreas Meyer-Lindenberg, M.D., Ph.D.](https://www.libd.org/events/libd-speaker-series-andreas-meyer-lindenberg-m-d-ph-d/) - Risk mechanisms for schizophrenia Andreas Meyer-Lindenberg, M.D., Ph.D. Director (and CEO), Central Institute of Mental Health, Mannheim Medical Director, Department of Psychiatry and Psychotherapy, Central Institute of Mental Health When: April 3 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Kristen Brennand, Ph.D.](https://www.libd.org/events/libd-speaker-series-kristen-brennand-ph-d/) - Modeling common variant risk to schizophrenia using stem cells. Kristen Brennand, Ph.D. New York Stem Cell Foundation-Robertson Investigator & Associate Professor, Icahn School of Medicine at Mount Sinai Departments of Psychiatry and Neuroscience When: May 15 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore,
- [LIBD Speaker Series: Matthew L. MacDonald, Ph.D.](https://www.libd.org/events/libd-speaker-series-matthew-l-macdonald-ph-d/) - Mapping Synaptic Protein and Phosphoprotein Networks Linked to Dendritic Spine Loss in Schizophrenia Matthew L. MacDonald, Ph.D. Assistant Professor of Psychiatry University of Pittsburgh, Department of Psychiatry When: March 20 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Helen S. Mayberg, M.D.](https://www.libd.org/events/lieber-speaker-series-helen-s-mayberg-m-d/) - In the Trenches: Balancing Progress and Setbacks with DBS for Depression Helen S. Mayberg, M.D. Professor Psychiatry, Neurology, and Radiology Emory University School of Medicine When: March 13 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Erica Korb, Ph.D.](https://www.libd.org/events/lieber-speaker-series-erica-korb-ph-d/) - Epigenetic regulation of neuronal function in Fragile X Syndrome Erica Korb, Ph.D. Postdoctoral Fellow Laboratory of Chromatin Biology and Epigenetics The Rockefeller University When: February 13 1:00pm-2:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Eli A. Stahl, Ph.D.](https://www.libd.org/events/libd-speaker-series-eli-a-stahl-ph-d/) - Parsing the hits in neuropsych disorders: pathways, networks and transcriptomes. Eli A. Stahl, Ph.D. Assistant Professor Genetics and Genomic Sciences, Psychiatry Icahn School of Medicine at Mount Sinai When: November 28 3:00pm-4:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Shaun Hopper, M.Sc.](https://www.libd.org/events/libd-speaker-series-shaun-hopper-m-sc/) - Muscarinic receptors in the cortical pathophysiology of schizophrenia. Shaun Hopper, M.Sc. The Florey Institute of Neuroscience and Mental Health The University of Melbourne When: December 11 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Bryan W. Luikart, Ph.D.](https://www.libd.org/events/libd-speaker-series-bryan-w-luikart-ph-d/) - Understanding the Neurobiological Basis of Autism Using PTEN as a Genetic Model Bryan W. Luikart, Ph.D. Assistant Professor Department of Molecular and Systems Biology Geisel School of Medicine at Dartmouth When: September 26 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Shawn Je, Ph.D.](https://www.libd.org/events/libd-speaker-series-shawn-je-ph-d/) - Synapse, Circuit, and Brain Disorders. Shawn Je, Ph.D. Assistant Professor Program in Neuroscience and Behavioral Disorders Duke-NUS Medical School When: July 28 10:00am-11:00am Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Carl Sellgren, M.D., Ph.D.](https://www.libd.org/events/libd-speaker-series/) - "Glia and Developmental Brain Disorders." Carl Sellgren, M.D., Ph.D. Postdoctoral Fellow Stanley Center & Psych Disease Broad Institute of MIT and Harvard When: June 29 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [LIBD Speaker Series: Ahmad Hariri, Ph.D.](https://www.libd.org/events/libd-speaker-series-ahmad-hariri-ph-d/) - Talk title coming soon! Ahmad Hariri, Ph.D. Professor of Psychology & Neuroscience at Duke University Director of the Laboratory of NeuroGenetics When: July 13 2:00pm-3:00pm Where: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [CONSTANCE LIEBER PRIZE SYMPOSIUM](https://www.libd.org/events/constance-lieber-prize-symposium/) - Constance Lieber Prize for Innovation in Developmental Neuroscience When: Tuesday, June 13 8:30am - 4:30pm Where: Johns Hopkins Medical Campus Chevy Chase Auditorium In addition to honoring the first recipient of this prize, Joseph Gleeson, MD, several keynote speakers will be in attendance to honor Constance Lieber's legacy. There will also be feature presentations from:
- [Speaker Series](https://www.libd.org/events/speaker-series-44/) - "Raising Tim: Our Mental Health Policy Mistakes and the Price My Son Paid" Paul Gionfriddo, Writer/Consultant, Our Health Policy Matters Time: 1:00 PM - 2:00 PM Place: The Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Meet the Scientist: A Virtual Q&A](https://www.libd.org/events/meet-the-scientist-a-virtual-qa/) - Daniel R. Weinberger, M.D., Director & CEO of the Lieber Institute for Brain Development will participate in the Brain & Behavior Research Foundation’s Meet the Scientist webinar. Dr. Weinberger will discuss “Research Discoveries in Schizophrenia" with the Foundation’s Acting President and CEO, Jeffrey Borenstein. Information on the webinar series and the registration page can be
- [Free Webinar](https://www.libd.org/events/free-webinar/) - Join PerkinElmer for a free webinar and discover how scientists are combining microscopy and high content analysis to advance research. The webinar will be hosted by Dan Hoeppner, an Investigator at the Lieber Institute. Click here to register.
- [Speaker Series](https://www.libd.org/events/speaker-series-43/) - "AKT Mediated D2R Signaling, Going Beyond Functional Selectivity" Dr. Martin Beaulieu from the Centre de recherche de l'Institut universitaire en santé mentale de Québec will present the talk. Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-42/) - "The Nature of Complex Inheritance: Hirschsprung Disease" Aravinda Chakravarti, Ph.D., Director, Center for Complex Disease Genomics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine. Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-41/) - "Depression, Genomic Medicine and the Limitations of the Disease Model in Psychiatry" Dr. Francis J. McMahon, MD, Chief, Human Genetics Branch and Genetic Basis of Mood and Anxiety Disorders Section, National Institute of Mental Health Intramural Research Program, will be our guest speaker. http://intramural.nimh.nih.gov/research/pi/pi_mcmahon_f.html Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development
- [Speaker Series](https://www.libd.org/events/speaker-series-40/) - "The Roles of Psychiatric Disease Genes in Brain Development and Synaptic Function" Li-Huei Tsai, Ph.D. Director, The Picower Institute for Learning and Memory Picower Professor of Neuroscience, Department of Brain and Cognitive Sciences Investigator, Howard Hughes Medical Institute http://www.lihueitsai.org/ Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main
- [Speaker Series](https://www.libd.org/events/speaker-series-39/) - "The Role of Postnatal Neurogenesis in the Dentate Gyrus" The talk will be presented by Dr. Helen Scharfman, Ph.D. of the Nathan Kline Institute for Psychiatric Research and New York University Langone Medical Center. www.sharfmanlab.com Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855
- [Speaker Series](https://www.libd.org/events/speaker-series-38/) - "Addiction: Conflict Between Brain Circuits" On Tuesday, July 9th we will welcome Nora D. Volkow, M.D., Director of the National Institute on Drug Abuse, to the Lieber Institute for a talk at 2:00pm. http://www.drugabuse.gov/about-nida/directors-page Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N.
- [Speaker Series](https://www.libd.org/events/speaker-series-37/) - "Rett Syndrome and Activity-Dependent Phosphorylation of MEC-P2" Daniel Ebert, M.D., Ph.D. will be visiting the Institute on September 13th. Dr. Ebert is a Postdoctoral Fellow in Dr. Michael Greenberg’s lab and an Instructor in the Neurobiology Department at Harvard Medical School. Time: 11:00 AM - 12:00 PM Place: The Lieber Institute for Brain Development Main
- [Speaker Series](https://www.libd.org/events/speaker-series-36/) - "The Impact of PTEN Dysfunction on Neuronal Form and Function: a Model for Autism" Bryan W Luikart, PhD Assistant Professor Department of Physiology & Neurobiology Geisel School of Medicine at Dartmouth Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St.
- [Speaker Series](https://www.libd.org/events/speaker-series-35/) - "Probing Human Brain Network Dynamics During Learning" Dr. Danielle S. Bassett Skirkanich Assistant Professor of Innovation Department of Bioengineering University of Pennsylvania Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-34/) - "Consequences of BDNF-TRKB Signaling" Moses V. Chao, Ph.D., Professor in the Departments of Cell Biology, Physiology, Neuroscience, Molecular Neurobiology and Psychiatry at the NYU School of Medicine Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-33/) - "In Search of the Molecular Basis Of Major Depressive Disorder" Paul Greengard, Ph.D. Vincent Astor Professor Laboratory of Molecular & Cellular Neuroscience The Rockefeller University 2000 Nobel Laureate in Physiology or Medicine Time: 3:00 PM - 4:30 PM Place: Main Level, Zayed Tower Chevy Chase Auditorium JHU Medical Campus
- [Speaker Series](https://www.libd.org/events/speaker-series-32/) - "Hippocampal Neurogenesis and Pattern Separation: Impact on Cognition and Mood" Rene Hen Ph.D., Professor, Departments of Psychiatry, Neuroscience and Pharmacology, Columbia University; Director, Division of Integrative Neuroscience, New York State Psychiatric Institute Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-31/) - "How Fixed Circuits Generate Flexible Behaviors" Cornelia Bargmann, Ph.D. Torsten N. Wiesel Professor at Rockefeller University Head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD
- [Speaker Series](https://www.libd.org/events/speaker-series-30/) - "Single Cell Transcriptome Analyses Reveal Secrets of Quiescent Adult Neural Stem Cells" Yi Eve Sun, Ph.D. Professor, Department of Psychiatry and Biobehavioral Sciences and the Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development
- [Speaker Series](https://www.libd.org/events/speaker-series-29/) - "The Limits of Evidence-Base Medicine" Glenn J. Treisman, M.D., Ph.D. Professor of Psychiatry and Behavioral Sciences and Medicine, Johns Hopkins University School of Medicine Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-28/) - "Neuronal Cell Migration and Brain Map Formation" Pasko Rakic, M.D., Ph.D. Professor of Neuroscience and Neurology, Chairman, Department of Neurobiology, and Director, Kavli Institute for Neuroscience at Yale University School of Medicine Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe
- [Speaker Series](https://www.libd.org/events/speaker-series-27/) - “Synthetic Lethal Screening in the CNS Reveals Age-Regulated Modulators of Huntington’s Disease Progression” Myriam Heiman, Ph.D. Assistant Professor of Neuroscience Department of Brain and Cognitive Sciences Massachusetts Institute of Technology Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore,
- [Speaker Series](https://www.libd.org/events/speaker-series-26/) - "Illuminating the Molecular Logic of Experience: Dependent Circuit Tuning in Frontal Cortex" Kuan Hong Wang, Ph.D. Investigator, Unit Chief Unit on Neural Circuits and Adaptive Behaviors Genes, Cognition and Psychosis Program National Institute of Mental Health / NIH Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf.
- [Speaker Series](https://www.libd.org/events/speaker-series-25/) - "Psychiatric Genetics: Making Better CNS Drugs, and Making CNS Drugs Better" C. Anthony Altar, Ph. D. Senior Vice-president, Neurosciences AssureRx Health, Inc. Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-24/) - "Understanding the OCD Brain: Using New Technologies to Build Bridges between Humans and Mice" Susanne Ahmari, MD, PhD Director, Translational OCD Laboratory Assistant Professor of Psychiatry University of Pittsburgh Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD
- [Speaker Series](https://www.libd.org/events/speaker-series-23/) - "Academic Drug Discovery and the Integration of Genomic Insights" Edward Holson, Ph.D. is the Director of Medicinal Chemistry at the Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard. In February 2008, Ed joined the medicinal chemistry group at the Stanley Center to design and implement strategies towards developing novel therapies in
- [Speaker Series](https://www.libd.org/events/speaker-series-22/) - "Electrophysiological Biomarkers of Disease State and Target Engagement" Steven J. Siegel, M.D., Ph.D. Professor, Department of Psychiatry Director, Translational Neuroscience Program, Director, Clinical Neuroscience Training Program, University of Pennsylvania Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD
- [Speaker Series](https://www.libd.org/events/speaker-series-21/) - "Supercharging Genetic Discovery via Data Sharing: Lessons from Axonopathies" Stephan Züchner, MD, PhD (Interim) Chair, Dr. John T. Macdonald Foundation Department of Human Genetics Professor for Human Genetics and Neurology John P. Hussman Institute for Human Genomics University of Miami Miller School of Medicine Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for
- [Speaker Series](https://www.libd.org/events/speaker-series-20/) - "Charting the Genotype-Phenotype Map: Lessons from Drosophila" Trudy F.C. Mackay, Ph.D., William Neal Reynolds Distinguished University Professor of Biological Sciences, Associate Member of Entomology, North Carolina State University Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-19/) - "The Human Brainome: Genome, Transcriptome, Proteome and Phenome Interaction in the Human Cortex" Amanda J. Myers, Ph.D. Associate Professor, University of Miami Miller School of Medicine Department of Psychiatry & Behavioral Sciences Program in Neuroscience Interdepartmental Program in Human Genetics and Genomics Center on Aging Time: 2:00 PM - 3:00 PM Place: The Lieber Institute
- [Speaker Series](https://www.libd.org/events/speaker-series-18/) - "Single Cell Sequencing Reveals Mosaic CNVS in Human Neurons" Mike McConnell, Ph.D. Assistant Professor of Biochemistry and Molecular Genetics, Neuroscience Graduate Program, Center for Brain Immunology and Glia, Center for Public Health Genomics, University of Virginia School of Medicine Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855
- [Speaker Series](https://www.libd.org/events/speaker-series-17/) - "Stem Cells as Tools to Understand Brain Development and Disorders" Hongjun Song, Ph.D. Professor of Neurology/Institute for Cell Engineering Director, Stem Cell Program at ICE Johns Hopkins School of Medicine Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore,
- [Speaker Series](https://www.libd.org/events/speaker-series-16/) - "Molecular Dissection of Synaptic Function in Neuropsychiatric Disorders" Shawn Je Ph.D. Assistant Professor Program in Neuroscience and Behavioral Disorders Duke-NUS Graduate Medical School Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-15/) - "Pharmacometric Modeling and Simulation in Psychiatry" Robert Bies, Ph.D. Associate Professor Department of Pharmaceutical Sciences School of Pharmacy and Pharmaceutical Sciences State University of New York at Buffalo Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-14/) - "From RNA Editing to RNA Silencing: How ADAR1 Responds to Stress" Kazuko Nishikura, Ph.D. Professor, The Wistar Institute Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-13/) - "Chemical Genomics of Neuropsychiatric Disorders: Targeting Neuroplasticity" Stephen J. Haggarty, PhD Associate Professor of Neurology Director, Chemical Neurobiology Laboratory Massachusetts General Hospital, Harvard Medical School Time: 2:00 - 3:00 pm Place: The Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-12/) - "The Role of BDNF and Slitrks in Neuropsychiatric Disorders" Francis S. Lee, M.D., Ph.D. Professor of Psychiatry, Pharmacology and Neuroscience Weill Cornell Medical College, Cornell University Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-11/) - "Defining the Epigenetic Origins of Mental Illness" Reid S. Alisch, PhD Assistant Professor, Department of Psychiatry University of Wisconsin School of Medicine and Public Health Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-7/) - "Stahl’s Favorite Controversies in Treating Psychiatric Disorders: The Future of Psychopharmacology" Stephen M. Stahl, MD, PhD Adjunct Professor of Psychiatry, University of California San Diego Chairman, Neuroscience Education Institute Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD
- [Speaker Series](https://www.libd.org/events/speaker-series-6/) - “Elevation of low-frequency (delta/theta) oscillations in schizophrenia: thalamic network mechanisms" John Lisman, PhD Zalman Abraham Kekst Chair in Neuroscience and Professor of Biology, Brandeis University Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-3/) - "Dementia Reimagined" Peter J. Whitehouse, M.D., Ph.D. Professor of Neurology and former or current professor of Psychiatry, Psychology, Cognitive Science, Neuroscience, Bioethics, History, Nursing and Organizational Behavior at Case Western Reserve University Professor of Medicine at the University of Toronto President of Intergenerational Schools International Time: 1:00 PM - 2:00 PM Place: The Lieber Institute
- [Speaker Series](https://www.libd.org/events/speaker-series-2/) - "Mapping the Neural Circuitry Substrate for Cognitive Dysfunction in Schizophrenia" David A. Lewis, M.D. Chairman, Dept. of Psychiatry, University of Pittsburgh Medical Director and Director of Research, Western Psychiatric Institute and Clinic Director, Translational Neuroscience Program Director, NIMH Conte Center for Translational Mental Health Research Time: 11:00 AM - 12:00 PM Place: The Lieber Institute
- [Speaker Series](https://www.libd.org/events/speaker-series/) - "Transcription, Translation, and the Candidate Cell Type" Joseph D. Dougherty, PhD Assistant Professor Dept of Genetics, Dept of Psychiatry, Washington University, St. Louis, MO Time: 11:00 AM - 12:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-5/) - "Building Tridimensional Models of the Human Cerebral Cortex to Study Development and Disease” Sergiu P. Pasca, M.D. Assistant Professor, Stanford University Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-4/) - "Understanding the neurobiology of prenatal development: a window into neuropsychiatric disorders” Flora Vaccarino, M.D. Harris Professor, Child Study Center and Department of Neurobiology, Yale University Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/1545/) - “Neuronal DNA Methylome: How Dynamic is it?” Hao Wu, Ph.D. Department of Genetics and the Epigenetics Program, Perelman School of Medicine, University of Pennsylvania Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-stem-cells-genes-mitochondria-interneurons-and-schizophrenia/) - “Stem Cells, Genes, Mitochondria, Interneurons, and Schizophrenia” Stewart Anderson M.D. Research Director, Child Psychiatry Children's Hospital of Philadelphia, UPenn School of Medicine Time: 2:00 PM - 3:00 PM Place: The Lieber Institute for Brain Development Rangos Building Main Conf. Room Suite 300 855 N. Wolfe St. Baltimore, MD 21205
- [Speaker Series](https://www.libd.org/events/speaker-series-10/) - "Combining (Epi)genetic and Imaging Data with Multivariate Data-Driven Models: N-Way Parallel ICA and Parallel Group ICA" Vince Calhoun, PhD Distinguished Professor, Departments of Electrical and Computer Engineering (primary) Neuroscience, Computer Science,and Psychiatry, The University of New Mexico Time: 2:00 PM - 3:00 PM Place: Lieber Institute for Brain Development Main Conference Room Suite 300 855
- [Speaker Series](https://www.libd.org/events/speaker-series-9/) - "Postmortem Human Brain and Schizophrenia: Big Data Analysis and Genetic Liability" Panagiotis Roussos, MD, PhD Assistant Professor, Department of Genetics and Genomic Sciences and Department of Psychiatry Icahn Institute for Genomics and Multiscale Biology Friedman Brain Institute Icahn School of Medicine at Mount Sinai The Leon and Norma Hess Center for Science and Medicine Time:
- [Speaker Series](https://www.libd.org/events/speaker-series-8/) - "Cell-Type Specific Phenotyping to Model Neurodevelopmental Disorders" Shawn Je, PhD Assistant Professor, Program in Neuroscience and Behavioral Disorders, Duke-NUS Medical School Adjunct Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore Time: 2:00 PM - 3:00 PM Place: Lieber Institute for Brain Development Main Conference Room Suite 300 855 N. Wolfe St.

## Categories

- [Uncategorized](https://www.libd.org/category/uncategorized/)
- [News](https://www.libd.org/category/news/)
- [Press Releases](https://www.libd.org/category/press_releases/)
- [Disease Areas](https://www.libd.org/category/diseases_areas/)
- [Schizophrenia](https://www.libd.org/category/diseases_areas/schizophrenia/)
- [PTSD](https://www.libd.org/category/diseases_areas/ptsd/)
- [Bipolar Disorder](https://www.libd.org/category/diseases_areas/bipolar-disorder/)
- [Suicide](https://www.libd.org/category/diseases_areas/suicide/)
- [Depression](https://www.libd.org/category/diseases_areas/depression/)
- [Health Disparities](https://www.libd.org/category/diseases_areas/health-disparities/)
- [Blog](https://www.libd.org/category/blog/)
- [Autism](https://www.libd.org/category/diseases_areas/autism/)

## Team Category

- [Scientific Leadership](https://www.libd.org/team_category/scientific_leadership/)
- [Executive Leadership](https://www.libd.org/team_category/executive_leadership/)
- [Investigators and Research Scientists](https://www.libd.org/team_category/investigators_and_research_scientists/)
- [All Staff](https://www.libd.org/team_category/staff/)
- [Research Areas](https://www.libd.org/team_category/research-areas/)
- [Functional Genomics](https://www.libd.org/team_category/functional-genomics/)
- [Data Science/Computational Biology](https://www.libd.org/team_category/data-science-computational-biology/)
- [Developmental Biology](https://www.libd.org/team_category/developmental-biology/)
- [Drug Discovery & Development](https://www.libd.org/team_category/drug-discovery-development/)
- [Molecular Psychiatry/Imaging Genetics](https://www.libd.org/team_category/molecular-psychiatry-imaging-genetics/)
- [Molecular Neuropathology](https://www.libd.org/team_category/molecular-neuropathology/)